Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-192-3p ACTB -0.64 0.00027 -0.06 0.43313 MirTarget -0.11 0 NA
2 hsa-miR-92a-3p ACTB 0.21 0.13429 -0.06 0.43313 miRNAWalker2 validate -0.1 6.0E-5 NA
3 hsa-miR-107 ACTG1 0.24 0.01708 -0.12 0.20938 miRanda; miRNATAP -0.12 0.01365 NA
4 hsa-miR-148a-5p ACTG1 -0.77 0 -0.12 0.20938 MirTarget; miRNATAP -0.17 0 NA
5 hsa-miR-193b-3p ACTG1 -0.17 0.27202 -0.12 0.20938 miRNAWalker2 validate -0.18 0 NA
6 hsa-miR-103a-3p AMOT 0.77 0 -0.9 0.00079 MirTarget -0.45 0.00011 NA
7 hsa-miR-107 AMOT 0.24 0.01708 -0.9 0.00079 MirTarget; PITA; miRanda; miRNATAP -0.41 0.00177 NA
8 hsa-miR-10b-3p AMOT 2.77 0 -0.9 0.00079 mirMAP -0.14 0.00214 NA
9 hsa-miR-16-1-3p AMOT 0.39 0.00112 -0.9 0.00079 mirMAP -0.31 0.00493 NA
10 hsa-miR-221-3p AMOT 1.12 0 -0.9 0.00079 miRNAWalker2 validate -0.32 9.0E-5 NA
11 hsa-miR-30d-5p AMOT 0.72 0 -0.9 0.00079 mirMAP -0.3 0.00241 NA
12 hsa-miR-330-5p AMOT 0.44 0.00533 -0.9 0.00079 miRanda -0.28 0.00054 NA
13 hsa-miR-362-3p AMOT 0.81 0 -0.9 0.00079 miRanda -0.29 0.00208 NA
14 hsa-miR-500a-5p AMOT 0.8 0 -0.9 0.00079 mirMAP -0.29 0.00067 NA
15 hsa-miR-501-5p AMOT 1.15 0 -0.9 0.00079 miRNATAP -0.29 3.0E-5 NA
16 hsa-miR-532-5p AMOT 1.03 0 -0.9 0.00079 MirTarget -0.37 0.00017 NA
17 hsa-miR-618 AMOT 0.14 0.51715 -0.9 0.00079 mirMAP -0.18 0.00497 NA
18 hsa-miR-766-3p AMOT 0.2 0.25723 -0.9 0.00079 MirTarget -0.36 0 NA
19 hsa-miR-106b-5p APC 0.65 0 -0.18 0.06792 miRNAWalker2 validate; miRTarBase -0.15 0.00024 23087084 miR 106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma; Moreover we demonstrated that miR-106b downregulates APC expression by directly targeting the 3'-untranslated region of APC messenger RNA; Taken together our results suggest that miR-106b plays an important role in promoting the proliferation of human hepatoma cells and presents a novel mechanism of micro RNA-mediated direct suppression of APC expression in cancer cells
20 hsa-miR-21-5p APC 1.51 0 -0.18 0.06792 miRNAWalker2 validate -0.17 0 23773491; 24832083 The prognostic significance of APC gene mutation and miR 21 expression in advanced stage colorectal cancer; The aim of this study was to analyse the association of APC gene mutation and miR-21 expression with clinical outcome in CRC patients; APC gene mutation and expression of APC and miR-21 were analysed by direct DNA sequencing and real-time reverse transcription polymerase chain reaction; APC gene expression was low in CRC and negatively correlated with miR-21 expression and gene mutation; In Taiwan downregulation of the APC gene in CRC correlated with gene mutation and miR-21 upregulation; APC mutation and miR-21 expression could be used to predict the clinical outcome of CRC especially in patients with advanced disease;MicroRNA 21 promotes tumour malignancy via increased nuclear translocation of β catenin and predicts poor outcome in APC mutated but not in APC wild type colorectal cancer; However in our preliminary data the prognostic value of miR-21 levels was observed only in adenomatous polyposis coli APC-mutated tumours not in APC-wild-type tumours; We enrolled 165 colorectal tumour to determine APC mutation miR-21 levels and nuclear β-catenin expression by direct sequencing real-time PCR and immunohistochemistry
21 hsa-let-7a-5p APC2 -0.33 0.00046 1.72 0 TargetScan -0.3 0.00538 NA
22 hsa-miR-125a-5p APC2 -0.91 0 1.72 0 mirMAP -0.2 0.0003 NA
23 hsa-miR-125b-5p APC2 -1.36 0 1.72 0 mirMAP -0.16 0.01164 NA
24 hsa-miR-185-3p APC2 -0.27 0.0854 1.72 0 MirTarget -0.13 0.04272 NA
25 hsa-miR-194-3p APC2 -0.77 3.0E-5 1.72 0 mirMAP -0.17 0.00111 NA
26 hsa-miR-199a-5p APC2 -1.99 0 1.72 0 mirMAP -0.1 0.00178 NA
27 hsa-miR-20a-3p APC2 -0.32 0.04679 1.72 0 mirMAP -0.25 7.0E-5 NA
28 hsa-miR-2355-5p APC2 -0.23 0.15791 1.72 0 mirMAP -0.14 0.01613 NA
29 hsa-miR-23b-5p APC2 -1.05 0 1.72 0 mirMAP -0.22 0.0013 NA
30 hsa-miR-28-5p APC2 -0.43 0 1.72 0 mirMAP -0.3 0.00527 NA
31 hsa-miR-340-3p APC2 -0.33 0.0033 1.72 0 mirMAP -0.22 0.01183 NA
32 hsa-miR-505-5p APC2 -0.77 1.0E-5 1.72 0 mirMAP -0.15 0.00924 NA
33 hsa-miR-107 AREG 0.24 0.01708 -1.67 0 miRanda -1.2 0 NA
34 hsa-miR-320a AXIN1 0.33 0.02214 0.3 0.00968 miRNAWalker2 validate -0.1 0.00946 NA
35 hsa-let-7b-3p AXIN2 -1.22 0 0.11 0.75298 miRNATAP -0.27 0.0205 NA
36 hsa-let-7g-3p AXIN2 -1.14 0 0.11 0.75298 MirTarget -0.33 0.01126 NA
37 hsa-miR-15b-5p AXIN2 0.23 0.08248 0.11 0.75298 miRTarBase; MirTarget; miRNATAP -0.45 0.00081 NA
38 hsa-miR-16-2-3p AXIN2 -0.03 0.80516 0.11 0.75298 mirMAP -0.64 0 NA
39 hsa-miR-16-5p AXIN2 -0.4 0.0001 0.11 0.75298 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.49 0.00421 NA
40 hsa-miR-195-3p AXIN2 -1.09 0 0.11 0.75298 mirMAP -0.31 0.00083 NA
41 hsa-miR-195-5p AXIN2 -1.86 0 0.11 0.75298 MirTarget; miRNATAP -0.25 0.00506 NA
42 hsa-miR-26b-3p AXIN2 -1.26 0 0.11 0.75298 MirTarget -0.59 3.0E-5 NA
43 hsa-miR-326 AXIN2 -1.88 0 0.11 0.75298 miRanda -0.36 2.0E-5 NA
44 hsa-miR-338-5p AXIN2 -0.22 0.25239 0.11 0.75298 miRNATAP -0.34 0.00017 NA
45 hsa-miR-424-5p AXIN2 -2.63 0 0.11 0.75298 MirTarget; miRNATAP -0.19 0.03018 NA
46 hsa-miR-497-5p AXIN2 -1.41 0 0.11 0.75298 MirTarget; miRNATAP -0.29 0.00329 NA
47 hsa-miR-616-3p AXIN2 -0.7 2.0E-5 0.11 0.75298 MirTarget -0.42 8.0E-5 NA
48 hsa-let-7a-2-3p BBC3 -1.19 0 0.8 0 MirTarget -0.19 0 NA
49 hsa-let-7g-3p BBC3 -1.14 0 0.8 0 MirTarget; miRNATAP -0.18 0.0001 NA
50 hsa-miR-101-3p BBC3 -1.48 0 0.8 0 miRNATAP -0.32 0 NA
51 hsa-miR-125b-5p BBC3 -1.36 0 0.8 0 miRNAWalker2 validate; miRTarBase -0.25 0 25184537 Thus far two of these target genes BBC3 and NEU1 that are tumor suppressor genes but not yet studied in PDAC appear to be functional targets of miR-125b since knockdown of miR125b caused their up regulation
52 hsa-miR-139-5p BBC3 -2.11 0 0.8 0 miRNATAP -0.23 0 NA
53 hsa-miR-140-5p BBC3 -0.22 0.01407 0.8 0 miRNATAP -0.25 0.0003 NA
54 hsa-miR-144-3p BBC3 -2.98 0 0.8 0 miRNATAP -0.11 0 NA
55 hsa-miR-27b-3p BBC3 -0.82 0 0.8 0 miRNATAP -0.2 0.00022 NA
56 hsa-miR-345-5p BBC3 -0.71 0 0.8 0 miRNATAP -0.17 4.0E-5 NA
57 hsa-miR-590-3p BBC3 -0.47 2.0E-5 0.8 0 miRanda -0.25 1.0E-5 NA
58 hsa-let-7b-5p BIRC5 -0.96 0 4.5 0 miRNAWalker2 validate -0.71 0 NA
59 hsa-miR-101-3p BIRC5 -1.48 0 4.5 0 miRNAWalker2 validate -1.33 0 NA
60 hsa-miR-10a-5p BIRC5 -1.48 0 4.5 0 miRNAWalker2 validate -0.71 0 NA
61 hsa-miR-203a-3p BIRC5 -1.34 9.0E-5 4.5 0 miRTarBase -0.13 0.00935 22713668; 27714672 Luciferase assays were also performed to validate BIRC5 and LASP1 as miR-203 targets; Both miR-203 and BIRC5 siRNA signicantly inhibited cell proliferation in TNBC cells; Moreover up-regulated of BIRC5 and LASP1 was able to abrogate the effects induced by transfection with the miR-203 precursor;miR 203 is a predictive biomarker for colorectal cancer and its expression is associated with BIRC5; The purpose of this study was to explore the role of miR-203 in colorectal cancer CRC and evaluate the correlation between miR-203 and BIRC5; Finally miR-203 expression was negatively associated with that of BIRC5 r = -0.8150 P < 0.05
62 hsa-miR-218-5p BIRC5 -0.5 0.03986 4.5 0 miRTarBase; MirTarget -0.14 0.03933 25473903; 25900794; 26442524 Survivin BIRC5 was subsequently identified as an important cervical cancer target of miR-218 using in silico prediction mRNA profiling and quantitative real-time PCR qRT-PCR;miR-218 binds survivin BIRC5 mRNA 3'-UTR and down-regulated reporter luciferase activity;MiR-218 promoted apoptosis inhibited cell proliferation and caused cell cycle arrest in CRC cells by suppressing BIRC5 expression; In conclusion we demonstrated that high miR-218 expression had a positive prognostic value in 5-FU-based treatments for CRC patients and discovered a novel mechanism mediated by miR-218 to promote apoptosis and to function synergistically with 5-FU to promote chemosensitivity by suppressing BIRC5 and TS in CRC
63 hsa-miR-30c-5p BIRC5 -0.43 0.00016 4.5 0 miRNAWalker2 validate -0.45 0.00191 NA
64 hsa-miR-335-5p BIRC5 -1.61 0 4.5 0 miRNAWalker2 validate; MirTarget -0.5 0 23232114 Genetic variation in a miR 335 binding site in BIRC5 alters susceptibility to lung cancer in Chinese Han populations; In support of the postulation that the 3' UTR SNP may directly affect miRNA-binding site reporter gene assays indicated BIRC5 was a direct target of miR-335 and the rs2239680 T>C change resulted in altered regulation of BIRC5 expression; Our findings defined a 3' UTR SNP in human BIRC5 oncogene that may increase individual susceptibility to lung cancer probably by attenuating the interaction between miR-335 and BIRC5
65 hsa-miR-542-3p BIRC5 -1.31 0 4.5 0 miRNAWalker2 validate; MirTarget; miRanda -0.82 0 NA
66 hsa-miR-32-3p BMP2 0.22 0.20722 -0.18 0.35911 mirMAP -0.14 0.01775 NA
67 hsa-miR-142-3p BMP4 -1.42 0 0.76 0.00257 PITA; miRanda -0.21 0.00115 NA
68 hsa-miR-590-3p BMP4 -0.47 2.0E-5 0.76 0.00257 miRanda -0.27 0.01577 NA
69 hsa-miR-130b-3p BMP6 0.69 0.00011 -1.04 0 MirTarget -0.26 0 NA
70 hsa-miR-301a-3p BMP6 0.84 0 -1.04 0 MirTarget -0.14 0.01206 NA
71 hsa-miR-362-3p BMP6 0.81 0 -1.04 0 miRanda -0.3 4.0E-5 NA
72 hsa-miR-454-3p BMP6 0.67 0 -1.04 0 MirTarget -0.22 0.00157 NA
73 hsa-miR-130b-5p BMP7 0.17 0.33761 0.83 0.04887 mirMAP -0.32 0.00583 NA
74 hsa-miR-1976 BMP7 -0.43 0.00325 0.83 0.04887 MirTarget -0.45 0.00115 NA
75 hsa-miR-22-3p BMP7 -0.63 0 0.83 0.04887 miRNAWalker2 validate; miRTarBase -0.87 1.0E-5 NA
76 hsa-miR-30a-5p BMP7 -0.63 0.00011 0.83 0.04887 mirMAP; miRNATAP -0.35 0.00579 NA
77 hsa-miR-30e-5p BMP7 -0.63 0 0.83 0.04887 mirMAP -0.58 0.00444 NA
78 hsa-miR-34a-5p BMP7 1.04 0 0.83 0.04887 miRNAWalker2 validate -0.45 0.00162 NA
79 hsa-miR-616-5p BMP7 0.15 0.40284 0.83 0.04887 mirMAP -0.33 0.0036 NA
80 hsa-miR-140-5p BMP8A -0.22 0.01407 1.39 0 miRanda -0.29 0.01813 NA
81 hsa-miR-146b-5p BMP8A 0.42 0.04574 1.39 0 miRanda -0.12 0.02024 NA
82 hsa-miR-194-3p BMP8A -0.77 3.0E-5 1.39 0 MirTarget -0.35 0 NA
83 hsa-miR-30b-3p BMP8A -0.44 0.00095 1.39 0 MirTarget -0.25 0.00222 NA
84 hsa-miR-30e-3p BMP8A -1.21 0 1.39 0 MirTarget -0.32 0.00032 NA
85 hsa-miR-455-5p BMP8A -0.27 0.05813 1.39 0 MirTarget; miRanda -0.22 0.00398 NA
86 hsa-miR-107 BMP8B 0.24 0.01708 0.28 0.41783 mirMAP -0.33 0.0496 NA
87 hsa-miR-33a-5p BMP8B -0.77 1.0E-5 0.28 0.41783 mirMAP -0.2 0.03788 NA
88 hsa-miR-618 BMP8B 0.14 0.51715 0.28 0.41783 mirMAP -0.24 0.00328 NA
89 hsa-miR-140-5p BMPR1A -0.22 0.01407 0.07 0.48504 miRanda -0.15 0.00409 NA
90 hsa-miR-130b-3p BMPR1B 0.69 0.00011 -3.31 0 miRNATAP -0.34 0.00049 NA
91 hsa-miR-140-3p BMPR1B 0.55 0 -3.31 0 MirTarget -1.09 0 NA
92 hsa-miR-362-3p BMPR1B 0.81 0 -3.31 0 MirTarget; miRanda -0.65 0 NA
93 hsa-miR-374a-5p BMPR1B 0.02 0.86978 -3.31 0 MirTarget -0.96 0 NA
94 hsa-miR-374b-5p BMPR1B -0.31 0.00301 -3.31 0 MirTarget -0.45 0.00882 NA
95 hsa-miR-421 BMPR1B 0.94 0 -3.31 0 miRanda -0.25 0.01483 NA
96 hsa-miR-106b-5p BMPR2 0.65 0 -0.74 0 MirTarget; miRNATAP -0.22 0 NA
97 hsa-miR-130b-3p BMPR2 0.69 0.00011 -0.74 0 MirTarget; miRNATAP -0.12 2.0E-5 NA
98 hsa-miR-148b-3p BMPR2 0.27 0.00185 -0.74 0 mirMAP -0.27 1.0E-5 NA
99 hsa-miR-17-5p BMPR2 0.7 2.0E-5 -0.74 0 miRNAWalker2 validate; MirTarget; TargetScan; miRNATAP -0.26 0 NA
100 hsa-miR-185-5p BMPR2 0.48 0 -0.74 0 MirTarget -0.25 0 NA
101 hsa-miR-19a-3p BMPR2 1.02 0 -0.74 0 miRNAWalker2 validate; MirTarget; miRNATAP -0.17 0 NA
102 hsa-miR-19b-3p BMPR2 0.6 0.00017 -0.74 0 miRNAWalker2 validate; MirTarget; miRNATAP -0.21 0 NA
103 hsa-miR-20a-5p BMPR2 0.85 0 -0.74 0 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.24 0 NA
104 hsa-miR-21-5p BMPR2 1.51 0 -0.74 0 miRNAWalker2 validate; miRTarBase; MirTarget -0.28 0 NA
105 hsa-miR-25-3p BMPR2 0.63 0 -0.74 0 miRNATAP -0.17 0.00117 NA
106 hsa-miR-29a-5p BMPR2 -0.11 0.34962 -0.74 0 mirMAP -0.15 0.00063 NA
107 hsa-miR-301a-3p BMPR2 0.84 0 -0.74 0 MirTarget; miRNATAP -0.11 0.00019 NA
108 hsa-miR-30d-5p BMPR2 0.72 0 -0.74 0 mirMAP -0.19 0 NA
109 hsa-miR-362-3p BMPR2 0.81 0 -0.74 0 MirTarget; PITA; miRanda; miRNATAP -0.18 0 NA
110 hsa-miR-455-5p BMPR2 -0.27 0.05813 -0.74 0 PITA -0.13 0.00044 NA
111 hsa-miR-532-5p BMPR2 1.03 0 -0.74 0 PITA -0.29 0 NA
112 hsa-miR-590-5p BMPR2 -0.1 0.31003 -0.74 0 MirTarget; PITA; miRNATAP -0.19 0.0002 NA
113 hsa-miR-618 BMPR2 0.14 0.51715 -0.74 0 PITA; mirMAP -0.1 5.0E-5 NA
114 hsa-miR-671-5p BMPR2 0.84 0 -0.74 0 miRNATAP -0.11 0.00171 NA
115 hsa-miR-769-5p BMPR2 0.22 0.03334 -0.74 0 miRNATAP -0.15 0.003 NA
116 hsa-miR-877-5p BMPR2 1.36 0 -0.74 0 MirTarget -0.15 0 NA
117 hsa-miR-92a-3p BMPR2 0.21 0.13429 -0.74 0 miRNAWalker2 validate; miRNATAP -0.24 0 NA
118 hsa-miR-93-3p BMPR2 0.4 0.00131 -0.74 0 miRNAWalker2 validate -0.19 0 NA
119 hsa-miR-93-5p BMPR2 1.4 0 -0.74 0 miRNAWalker2 validate; MirTarget; miRNATAP -0.27 0 NA
120 hsa-miR-15b-5p BTRC 0.23 0.08248 -0 0.97671 MirTarget; miRNATAP -0.12 0 NA
121 hsa-miR-16-5p BTRC -0.4 0.0001 -0 0.97671 miRNAWalker2 validate; MirTarget; miRNATAP -0.17 0 NA
122 hsa-miR-193a-3p BTRC -0.12 0.30939 -0 0.97671 MirTarget; miRanda -0.15 0 NA
123 hsa-miR-193b-3p BTRC -0.17 0.27202 -0 0.97671 miRNAWalker2 validate -0.16 0 NA
124 hsa-miR-361-3p BTRC 0.28 0.00549 -0 0.97671 MirTarget; PITA; miRNATAP -0.1 0.00495 NA
125 hsa-miR-497-5p BTRC -1.41 0 -0 0.97671 MirTarget; miRNATAP -0.11 0 NA
126 hsa-miR-505-3p BTRC -1.2 0 -0 0.97671 MirTarget -0.13 0 NA
127 hsa-miR-106a-5p CCND1 -0.46 0.00972 -0.9 1.0E-5 MirTarget; miRNATAP -0.26 0 NA
128 hsa-miR-106b-5p CCND1 0.65 0 -0.9 1.0E-5 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.43 0 NA
129 hsa-miR-1266-5p CCND1 1.63 0 -0.9 1.0E-5 MirTarget -0.23 0 NA
130 hsa-miR-15b-5p CCND1 0.23 0.08248 -0.9 1.0E-5 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.54 0 NA
131 hsa-miR-16-5p CCND1 -0.4 0.0001 -0.9 1.0E-5 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.31 0.00178 23991964; 22922827; 18483394 At the molecular level our results further revealed that cyclin D1 expression was negatively regulated by miR-16;CCND1 has been found to be a target of miR-15a and miR-16-1 through analysis of complementary sequences between microRNAs and CCND1 mRNA; Moreover the transcription of CCND1 is suppressed by miR-15a and miR-16-1 via direct binding to the CCND1 3'-untranslated region 3'-UTR;Truncation in CCND1 mRNA alters miR 16 1 regulation in mantle cell lymphoma; Furthermore we demonstrated that this truncation alters miR-16-1 binding sites and through the use of reporter constructs we were able to show that miR-16-1 regulates CCND1 mRNA expression; This study introduces the role of miR-16-1 in the regulation of CCND1 in MCL
132 hsa-miR-17-5p CCND1 0.7 2.0E-5 -0.9 1.0E-5 miRNAWalker2 validate; MirTarget; TargetScan; miRNATAP -0.34 0 26431674 Bioinformatics Prediction and In Vitro Analysis Revealed That miR 17 Targets Cyclin D1 mRNA in Triple Negative Breast Cancer Cells; In this study using bioinformatic analyses miR-17 was selected as it targets the 3'UTR of CCND1 gene with the highest score; After lentiviral transduction of miR-17 to the target cells gene expression analysis showed decreased expression of CCND1 gene
133 hsa-miR-186-5p CCND1 -0.06 0.53529 -0.9 1.0E-5 mirMAP -0.32 0.00286 NA
134 hsa-miR-193a-3p CCND1 -0.12 0.30939 -0.9 1.0E-5 MirTarget; PITA; miRanda -0.21 0.01806 NA
135 hsa-miR-19a-3p CCND1 1.02 0 -0.9 1.0E-5 miRNAWalker2 validate; miRTarBase; miRNATAP -0.28 0 25985117 Moreover miR-19a might play inhibitory roles in HCC malignancy via regulating Cyclin D1 expression
136 hsa-miR-19b-1-5p CCND1 -0.28 0.07831 -0.9 1.0E-5 miRNAWalker2 validate; miRTarBase -0.31 0 NA
137 hsa-miR-19b-3p CCND1 0.6 0.00017 -0.9 1.0E-5 miRNATAP -0.34 0 NA
138 hsa-miR-20a-5p CCND1 0.85 0 -0.9 1.0E-5 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.33 0 NA
139 hsa-miR-20b-5p CCND1 0.46 0.02859 -0.9 1.0E-5 MirTarget; miRNATAP -0.23 0 NA
140 hsa-miR-340-5p CCND1 -0 0.9685 -0.9 1.0E-5 mirMAP -0.32 0.00013 NA
141 hsa-miR-425-5p CCND1 0.59 2.0E-5 -0.9 1.0E-5 miRNAWalker2 validate -0.39 0 NA
142 hsa-miR-503-5p CCND1 0.19 0.26842 -0.9 1.0E-5 miRNAWalker2 validate; miRTarBase; MirTarget -0.16 0.00815 26047605; 23731275 MiR 503 inhibited cell proliferation of human breast cancer cells by suppressing CCND1 expression; Overexpression of miR-503 in breast cancer cell lines reduced cell proliferation through inducing G0/G1 cell cycle arrest by targeting CCND1;MicroRNA 503 suppresses proliferation and cell cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1; CCND1 has a binding sequence of miR-503 within its 3' untranslated region and was confirmed to be a direct target of miR-503 by the fluorescent reporter assays; Increasing the miR-503 level in EEC cells suppressed cell viability colon formation activity and cell-cycle progression and the inhibited oncogenic phenotypes induced by miR-503 were alleviated by ectopic expression of CCND1 without the untranslated region sequence; Collectively this study suggested that miR-503 plays a tumor-suppressor role by targeting CCND1; Abnormal suppression of miR-503 leads to an increase in the CCND1 level which may promote carcinogenesis and progression of EEC
143 hsa-miR-589-3p CCND1 1.17 0 -0.9 1.0E-5 MirTarget -0.18 0.00124 NA
144 hsa-miR-616-5p CCND1 0.15 0.40284 -0.9 1.0E-5 mirMAP -0.26 1.0E-5 NA
145 hsa-miR-7-1-3p CCND1 -0.57 2.0E-5 -0.9 1.0E-5 mirMAP -0.26 0.00057 NA
146 hsa-miR-9-5p CCND1 1.26 9.0E-5 -0.9 1.0E-5 miRNAWalker2 validate -0.14 1.0E-5 NA
147 hsa-miR-92a-3p CCND1 0.21 0.13429 -0.9 1.0E-5 miRNAWalker2 validate -0.41 0 NA
148 hsa-miR-93-5p CCND1 1.4 0 -0.9 1.0E-5 miRNAWalker2 validate; MirTarget; miRNATAP -0.34 0 NA
149 hsa-miR-942-5p CCND1 0.35 0.02833 -0.9 1.0E-5 MirTarget -0.25 0.00012 NA
150 hsa-miR-130b-5p CCND2 0.17 0.33761 0.36 0.03656 mirMAP -0.17 0.00018 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 CANONICAL WNT SIGNALING PATHWAY 31 95 6.096e-46 2.836e-42
2 ORGAN MORPHOGENESIS 56 841 1.437e-43 3.342e-40
3 EPITHELIUM DEVELOPMENT 58 945 2.599e-43 4.031e-40
4 WNT SIGNALING PATHWAY 42 351 1.41e-42 1.64e-39
5 TISSUE DEVELOPMENT 66 1518 1.016e-40 9.46e-38
6 TISSUE MORPHOGENESIS 46 533 3.076e-40 2.386e-37
7 REGULATION OF WNT SIGNALING PATHWAY 38 310 8.857e-39 5.887e-36
8 NEUROGENESIS 62 1402 3.066e-38 1.783e-35
9 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 34 236 4.506e-37 2.329e-34
10 REGULATION OF PHOSPHORUS METABOLIC PROCESS 64 1618 8.966e-37 4.172e-34
11 REGULATION OF PROTEIN MODIFICATION PROCESS 65 1710 2.069e-36 8.75e-34
12 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 64 1672 6.403e-36 2.483e-33
13 TUBE DEVELOPMENT 43 552 1.465e-35 5.242e-33
14 POSITIVE REGULATION OF RESPONSE TO STIMULUS 66 1929 2.769e-34 8.59e-32
15 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 52 1021 2.746e-34 8.59e-32
16 REGULATION OF CELL DIFFERENTIATION 59 1492 2.082e-33 6.054e-31
17 MORPHOGENESIS OF AN EPITHELIUM 37 400 3.894e-33 1.066e-30
18 POSITIVE REGULATION OF CELL COMMUNICATION 59 1532 8.888e-33 2.298e-30
19 EMBRYONIC MORPHOGENESIS 40 539 3.939e-32 9.646e-30
20 NEGATIVE REGULATION OF CELL COMMUNICATION 53 1192 4.57e-32 1.063e-29
21 REGULATION OF CELLULAR PROTEIN LOCALIZATION 40 552 1.002e-31 2.22e-29
22 RESPONSE TO GROWTH FACTOR 38 475 1.114e-31 2.355e-29
23 CELL DEVELOPMENT 56 1426 2.662e-31 5.385e-29
24 TUBE MORPHOGENESIS 33 323 6.596e-31 1.279e-28
25 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 51 1142 8.222e-31 1.53e-28
26 REGULATION OF ORGAN MORPHOGENESIS 30 242 1.227e-30 2.195e-28
27 NEURON DIFFERENTIATION 46 874 1.317e-30 2.219e-28
28 POSITIVE REGULATION OF CELL DIFFERENTIATION 45 823 1.335e-30 2.219e-28
29 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 56 1492 2.768e-30 4.418e-28
30 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 54 1360 2.848e-30 4.418e-28
31 POSITIVE REGULATION OF GENE EXPRESSION 59 1733 7.2e-30 1.081e-27
32 SENSORY ORGAN DEVELOPMENT 37 493 8.258e-30 1.201e-27
33 CELL FATE COMMITMENT 28 227 1.561e-28 2.201e-26
34 EMBRYO DEVELOPMENT 44 894 5.699e-28 7.799e-26
35 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 48 1135 9.125e-28 1.213e-25
36 REGULATION OF CELL DEATH 53 1472 1.428e-27 1.846e-25
37 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 46 1036 2.062e-27 2.525e-25
38 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 46 1036 2.062e-27 2.525e-25
39 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 26 197 2.688e-27 3.207e-25
40 HIPPO SIGNALING 15 27 5.941e-27 6.911e-25
41 REGULATION OF PROTEIN LOCALIZATION 44 950 6.981e-27 7.922e-25
42 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 44 957 9.437e-27 1.045e-24
43 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 41 801 1.315e-26 1.423e-24
44 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 57 1848 1.743e-26 1.824e-24
45 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 24 162 1.764e-26 1.824e-24
46 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 25 190 3.159e-26 3.195e-24
47 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 56 1805 4.489e-26 4.444e-24
48 REGULATION OF CELL DEVELOPMENT 41 836 6.834e-26 6.624e-24
49 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 35 554 1.289e-25 1.224e-23
50 REGULATION OF CELL PROLIFERATION 51 1496 2.612e-25 2.431e-23
51 EMBRYONIC ORGAN DEVELOPMENT 31 406 4.027e-25 3.674e-23
52 REGULATION OF CELLULAR LOCALIZATION 47 1277 1.554e-24 1.39e-22
53 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 33 513 2.246e-24 1.972e-22
54 HEAD DEVELOPMENT 37 709 3.372e-24 2.905e-22
55 REGULATION OF OSSIFICATION 23 178 5.553e-24 4.698e-22
56 REGULATION OF STEM CELL DIFFERENTIATION 20 113 8.327e-24 6.919e-22
57 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 42 1008 8.48e-24 6.923e-22
58 GROWTH 30 410 9.099e-24 7.299e-22
59 CARDIOVASCULAR SYSTEM DEVELOPMENT 38 788 1.181e-23 9.16e-22
60 CIRCULATORY SYSTEM DEVELOPMENT 38 788 1.181e-23 9.16e-22
61 POSITIVE REGULATION OF CELL DEATH 34 605 3.202e-23 2.442e-21
62 POSITIVE REGULATION OF CELL DEVELOPMENT 31 472 3.736e-23 2.804e-21
63 GLAND DEVELOPMENT 29 395 5.11e-23 3.774e-21
64 CELL PROLIFERATION 35 672 7.929e-23 5.765e-21
65 CELLULAR COMPONENT MORPHOGENESIS 39 900 1.269e-22 9.083e-21
66 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 16 60 2.387e-22 1.683e-20
67 REGULATION OF OSTEOBLAST DIFFERENTIATION 19 112 2.769e-22 1.923e-20
68 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 15 48 3.351e-22 2.293e-20
69 REGULATION OF EMBRYONIC DEVELOPMENT 19 114 3.954e-22 2.667e-20
70 REGULATION OF MAPK CASCADE 34 660 5.201e-22 3.457e-20
71 REGULATION OF CARTILAGE DEVELOPMENT 16 63 5.757e-22 3.773e-20
72 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 15 50 6.829e-22 4.413e-20
73 BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY 12 22 1.268e-21 8.085e-20
74 CARTILAGE DEVELOPMENT 20 147 2.086e-21 1.311e-19
75 RESPONSE TO ENDOGENOUS STIMULUS 46 1450 2.619e-21 1.625e-19
76 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 22 207 4.581e-21 2.805e-19
77 SMAD PROTEIN SIGNAL TRANSDUCTION 15 56 4.78e-21 2.889e-19
78 NEGATIVE REGULATION OF CELL DIFFERENTIATION 32 609 5.861e-21 3.496e-19
79 GASTRULATION 20 155 6.219e-21 3.663e-19
80 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 19 131 6.321e-21 3.677e-19
81 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 13 34 9.718e-21 5.582e-19
82 EMBRYONIC ORGAN MORPHOGENESIS 24 279 9.993e-21 5.67e-19
83 REGULATION OF INTRACELLULAR TRANSPORT 32 621 1.052e-20 5.897e-19
84 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 41 1152 1.183e-20 6.551e-19
85 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 22 218 1.439e-20 7.879e-19
86 MESENCHYME DEVELOPMENT 21 190 1.68e-20 9.091e-19
87 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 22 220 1.76e-20 9.414e-19
88 NON CANONICAL WNT SIGNALING PATHWAY 19 140 2.341e-20 1.238e-18
89 CONNECTIVE TISSUE DEVELOPMENT 21 194 2.614e-20 1.367e-18
90 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 38 983 2.664e-20 1.377e-18
91 MORPHOGENESIS OF A BRANCHING STRUCTURE 20 167 2.863e-20 1.464e-18
92 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 44 1395 3.277e-20 1.658e-18
93 SKELETAL SYSTEM DEVELOPMENT 28 455 3.658e-20 1.83e-18
94 HEART DEVELOPMENT 28 466 6.914e-20 3.422e-18
95 POSITIVE REGULATION OF OSSIFICATION 16 84 9.006e-20 4.411e-18
96 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 15 67 9.607e-20 4.656e-18
97 REGULATION OF PROTEIN IMPORT 20 183 1.833e-19 8.792e-18
98 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 48 1784 2.536e-19 1.204e-17
99 REGULATION OF EPITHELIAL CELL PROLIFERATION 23 285 2.921e-19 1.373e-17
100 EPITHELIAL CELL DIFFERENTIATION 28 495 3.427e-19 1.595e-17
101 CENTRAL NERVOUS SYSTEM DEVELOPMENT 35 872 3.595e-19 1.656e-17
102 EYE DEVELOPMENT 24 326 3.867e-19 1.764e-17
103 REGULATION OF TRANSFERASE ACTIVITY 36 946 5.597e-19 2.528e-17
104 RESPONSE TO BMP 16 94 6.146e-19 2.723e-17
105 CELLULAR RESPONSE TO BMP STIMULUS 16 94 6.146e-19 2.723e-17
106 PATTERN SPECIFICATION PROCESS 26 418 7.313e-19 3.21e-17
107 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 18 141 7.695e-19 3.346e-17
108 MAMMARY GLAND DEVELOPMENT 17 117 7.821e-19 3.369e-17
109 REGULATION OF KINASE ACTIVITY 33 776 8.2e-19 3.501e-17
110 UROGENITAL SYSTEM DEVELOPMENT 23 299 8.578e-19 3.629e-17
111 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 18 144 1.135e-18 4.756e-17
112 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 16 100 1.747e-18 7.26e-17
113 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 32 750 2.789e-18 1.149e-16
114 NEGATIVE REGULATION OF CELL PROLIFERATION 30 643 3.3e-18 1.347e-16
115 HEART MORPHOGENESIS 20 212 3.494e-18 1.414e-16
116 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 24 360 3.846e-18 1.543e-16
117 REGULATION OF APOPTOTIC SIGNALING PATHWAY 24 363 4.656e-18 1.851e-16
118 CELL JUNCTION ORGANIZATION 19 185 5.128e-18 2.022e-16
119 MESENCHYMAL CELL DIFFERENTIATION 17 134 8.458e-18 3.303e-16
120 STEM CELL DIFFERENTIATION 19 190 8.518e-18 3.303e-16
121 RESPIRATORY SYSTEM DEVELOPMENT 19 197 1.691e-17 6.504e-16
122 EPITHELIAL TO MESENCHYMAL TRANSITION 13 56 1.764e-17 6.729e-16
123 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 18 171 2.613e-17 9.884e-16
124 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 42 1517 3.614e-17 1.356e-15
125 REGULATION OF CELL MORPHOGENESIS 27 552 6.332e-17 2.357e-15
126 OSSIFICATION 20 251 9.741e-17 3.597e-15
127 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 26 514 1.151e-16 4.215e-15
128 DEVELOPMENTAL GROWTH 22 333 1.333e-16 4.844e-15
129 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 43 1656 1.388e-16 5.008e-15
130 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 25 470 1.493e-16 5.345e-15
131 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 22 337 1.713e-16 6.085e-15
132 MESODERM MORPHOGENESIS 13 66 1.812e-16 6.339e-15
133 LENS DEVELOPMENT IN CAMERA TYPE EYE 13 66 1.812e-16 6.339e-15
134 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 29 689 2.02e-16 7.015e-15
135 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 16 134 2.215e-16 7.627e-15
136 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 17 162 2.229e-16 7.627e-15
137 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 34 1004 2.256e-16 7.662e-15
138 POSITIVE REGULATION OF CELL PROLIFERATION 31 814 2.502e-16 8.435e-15
139 FORMATION OF PRIMARY GERM LAYER 15 110 2.614e-16 8.75e-15
140 REGULATION OF PROTEIN TARGETING 21 307 3.472e-16 1.154e-14
141 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 11 38 3.785e-16 1.24e-14
142 MESENCHYME MORPHOGENESIS 11 38 3.785e-16 1.24e-14
143 MESONEPHROS DEVELOPMENT 14 90 3.986e-16 1.297e-14
144 MAMMARY GLAND EPITHELIUM DEVELOPMENT 12 53 4.449e-16 1.438e-14
145 REGIONALIZATION 21 311 4.507e-16 1.446e-14
146 SENSORY ORGAN MORPHOGENESIS 19 239 6.316e-16 2.013e-14
147 MESODERM DEVELOPMENT 15 118 7.715e-16 2.442e-14
148 NEGATIVE REGULATION OF GENE EXPRESSION 40 1493 8.004e-16 2.516e-14
149 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 14 95 8.782e-16 2.742e-14
150 REGULATION OF BINDING 20 283 9.991e-16 3.099e-14
151 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 16 152 1.7e-15 5.239e-14
152 KIDNEY EPITHELIUM DEVELOPMENT 15 125 1.864e-15 5.707e-14
153 PROTEIN PHOSPHORYLATION 32 944 2.031e-15 6.176e-14
154 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 16 154 2.097e-15 6.337e-14
155 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 22 381 2.221e-15 6.666e-14
156 PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 8 13 2.326e-15 6.921e-14
157 POSITIVE REGULATION OF MOLECULAR FUNCTION 43 1791 2.335e-15 6.921e-14
158 CELLULAR MACROMOLECULE LOCALIZATION 36 1234 2.52e-15 7.422e-14
159 POSITIVE REGULATION OF KINASE ACTIVITY 24 482 2.835e-15 8.297e-14
160 REGULATION OF TRANSPORT 43 1804 3.022e-15 8.788e-14
161 ANTERIOR POSTERIOR PATTERN SPECIFICATION 17 194 4.696e-15 1.357e-13
162 PALATE DEVELOPMENT 13 85 5.928e-15 1.703e-13
163 NEGATIVE REGULATION OF GROWTH 18 236 8.034e-15 2.293e-13
164 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 26 616 8.613e-15 2.444e-13
165 REPRODUCTIVE SYSTEM DEVELOPMENT 22 408 9.118e-15 2.571e-13
166 REGULATION OF STEM CELL PROLIFERATION 13 88 9.484e-15 2.658e-13
167 PROTEIN COMPLEX SUBUNIT ORGANIZATION 39 1527 9.919e-15 2.764e-13
168 MIDBRAIN DEVELOPMENT 13 90 1.285e-14 3.558e-13
169 REGULATION OF CELL ADHESION 26 629 1.407e-14 3.873e-13
170 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 21 370 1.438e-14 3.936e-13
171 POSITIVE REGULATION OF MAPK CASCADE 23 470 1.664e-14 4.51e-13
172 REGULATION OF CELL CYCLE 31 949 1.667e-14 4.51e-13
173 CELL CYCLE 36 1316 1.809e-14 4.866e-13
174 REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 8 16 2.29e-14 6.124e-13
175 REGULATION OF ORGANELLE ORGANIZATION 34 1178 2.501e-14 6.65e-13
176 INTRACELLULAR SIGNAL TRANSDUCTION 39 1572 2.548e-14 6.736e-13
177 NEURAL TUBE DEVELOPMENT 15 149 2.654e-14 6.977e-13
178 REGULATION OF CYTOPLASMIC TRANSPORT 23 481 2.716e-14 7.1e-13
179 GLAND MORPHOGENESIS 13 97 3.513e-14 9.131e-13
180 RHYTHMIC PROCESS 19 298 3.589e-14 9.277e-13
181 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 25 602 4.384e-14 1.127e-12
182 DEVELOPMENTAL INDUCTION 9 27 4.631e-14 1.177e-12
183 REGULATION OF CATENIN IMPORT INTO NUCLEUS 9 27 4.631e-14 1.177e-12
184 OSTEOBLAST DIFFERENTIATION 14 126 5.038e-14 1.274e-12
185 TUBE FORMATION 14 129 7.021e-14 1.766e-12
186 IN UTERO EMBRYONIC DEVELOPMENT 19 311 7.751e-14 1.939e-12
187 STEM CELL PROLIFERATION 11 60 9.606e-14 2.365e-12
188 CHONDROCYTE DIFFERENTIATION 11 60 9.606e-14 2.365e-12
189 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 11 60 9.606e-14 2.365e-12
190 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 9 29 9.792e-14 2.398e-12
191 SINGLE ORGANISM CELL ADHESION 22 459 1.005e-13 2.438e-12
192 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 32 1087 1.011e-13 2.438e-12
193 ODONTOGENESIS 13 105 1.009e-13 2.438e-12
194 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 16 197 1.035e-13 2.482e-12
195 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 20 365 1.251e-13 2.986e-12
196 REGULATION OF GROWTH 25 633 1.353e-13 3.213e-12
197 SKELETAL SYSTEM MORPHOGENESIS 16 201 1.416e-13 3.345e-12
198 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY 13 110 1.867e-13 4.387e-12
199 REGULATION OF CHONDROCYTE DIFFERENTIATION 10 46 2.126e-13 4.971e-12
200 POSITIVE REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 7 12 2.426e-13 5.643e-12
201 POSITIVE REGULATION OF CATALYTIC ACTIVITY 37 1518 2.484e-13 5.751e-12
202 REGULATION OF ORGAN FORMATION 9 32 2.7e-13 6.219e-12
203 NEGATIVE REGULATION OF CELL CYCLE 21 433 3.095e-13 7.094e-12
204 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 23 541 3.192e-13 7.244e-12
205 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 23 541 3.192e-13 7.244e-12
206 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 42 1977 3.669e-13 8.288e-12
207 PHOSPHORYLATION 33 1228 4.832e-13 1.086e-11
208 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 24 616 5.97e-13 1.336e-11
209 NEURAL TUBE FORMATION 12 94 6.425e-13 1.43e-11
210 REGULATION OF HYDROLASE ACTIVITY 34 1327 7.532e-13 1.669e-11
211 NEURON DEVELOPMENT 25 687 8.332e-13 1.837e-11
212 POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 9 36 8.873e-13 1.948e-11
213 FOREBRAIN DEVELOPMENT 19 357 9.069e-13 1.981e-11
214 RESPONSE TO LIPID 28 888 9.279e-13 2.017e-11
215 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 16 229 1.066e-12 2.307e-11
216 LOCOMOTION 31 1114 1.175e-12 2.531e-11
217 REGULATION OF DEPHOSPHORYLATION 14 158 1.185e-12 2.541e-11
218 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 11 75 1.269e-12 2.709e-11
219 EAR DEVELOPMENT 15 195 1.411e-12 2.997e-11
220 REGULATION OF MAP KINASE ACTIVITY 18 319 1.421e-12 3.004e-11
221 REGULATION OF CELLULAR COMPONENT MOVEMENT 26 771 1.533e-12 3.229e-11
222 WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY 9 39 1.966e-12 4.121e-11
223 RESPONSE TO ORGANIC CYCLIC COMPOUND 28 917 2.008e-12 4.19e-11
224 PROTEIN LOCALIZATION 39 1805 2.058e-12 4.275e-11
225 MAMMARY GLAND MORPHOGENESIS 9 40 2.524e-12 5.219e-11
226 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 13 135 2.703e-12 5.566e-11
227 REGULATION OF FAT CELL DIFFERENTIATION 12 106 2.781e-12 5.7e-11
228 RESPONSE TO RETINOIC ACID 12 107 3.116e-12 6.358e-11
229 CELL CYCLE PROCESS 30 1081 3.153e-12 6.406e-11
230 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 17 289 3.213e-12 6.5e-11
231 PARAXIAL MESODERM DEVELOPMENT 7 16 3.432e-12 6.913e-11
232 NEGATIVE REGULATION OF CELL DEATH 27 872 3.88e-12 7.782e-11
233 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 25 740 4.239e-12 8.466e-11
234 REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 9 43 5.124e-12 1.019e-10
235 NEGATIVE REGULATION OF CELL DEVELOPMENT 17 303 6.833e-12 1.353e-10
236 REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY 8 29 7.136e-12 1.395e-10
237 POSITIVE REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY 8 29 7.136e-12 1.395e-10
238 REGULATION OF HEART MORPHOGENESIS 8 29 7.136e-12 1.395e-10
239 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 22 573 8.265e-12 1.609e-10
240 CELLULAR RESPONSE TO RETINOIC ACID 10 65 8.452e-12 1.639e-10
241 CELL DIVISION 20 460 8.811e-12 1.687e-10
242 DIGESTIVE SYSTEM DEVELOPMENT 13 148 8.808e-12 1.687e-10
243 SEGMENTATION 11 89 8.792e-12 1.687e-10
244 POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 12 119 1.12e-11 2.136e-10
245 DORSAL VENTRAL PATTERN FORMATION 11 91 1.128e-11 2.141e-10
246 REPRODUCTION 32 1297 1.142e-11 2.159e-10
247 RESPONSE TO OXYGEN CONTAINING COMPOUND 33 1381 1.182e-11 2.227e-10
248 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 12 121 1.367e-11 2.565e-10
249 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 18 368 1.545e-11 2.886e-10
250 NEGATIVE REGULATION OF MOLECULAR FUNCTION 29 1079 1.701e-11 3.167e-10
251 POSITIVE REGULATION OF TRANSPORT 27 936 1.972e-11 3.655e-10
252 DORSAL VENTRAL AXIS SPECIFICATION 7 20 2.278e-11 4.206e-10
253 NEURON PROJECTION DEVELOPMENT 21 545 2.437e-11 4.482e-10
254 REGULATION OF CELL CELL ADHESION 18 380 2.623e-11 4.804e-10
255 CELL JUNCTION ASSEMBLY 12 129 2.93e-11 5.346e-10
256 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 19 437 3.073e-11 5.585e-10
257 REGULATION OF DEVELOPMENTAL GROWTH 16 289 3.622e-11 6.557e-10
258 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 31 1275 3.752e-11 6.767e-10
259 REGULATION OF PROTEIN BINDING 13 168 4.404e-11 7.912e-10
260 REGULATION OF MUSCLE TISSUE DEVELOPMENT 11 103 4.462e-11 7.955e-10
261 REGULATION OF MUSCLE ORGAN DEVELOPMENT 11 103 4.462e-11 7.955e-10
262 REGULATION OF CELLULAR RESPONSE TO STRESS 23 691 4.642e-11 8.244e-10
263 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 11 104 4.964e-11 8.782e-10
264 CELL ACTIVATION 21 568 5.249e-11 9.25e-10
265 PROTEIN COMPLEX BIOGENESIS 29 1132 5.373e-11 9.399e-10
266 PROTEIN COMPLEX ASSEMBLY 29 1132 5.373e-11 9.399e-10
267 REGULATION OF KIDNEY DEVELOPMENT 9 55 5.426e-11 9.455e-10
268 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 19 465 8.875e-11 1.541e-09
269 CELL DEATH 27 1001 8.987e-11 1.555e-09
270 KIDNEY MORPHOGENESIS 10 82 9.239e-11 1.592e-09
271 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 15 262 9.652e-11 1.657e-09
272 VASCULATURE DEVELOPMENT 19 469 1.026e-10 1.756e-09
273 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 10 84 1.18e-10 2.011e-09
274 NEGATIVE REGULATION OF PHOSPHORYLATION 18 422 1.453e-10 2.468e-09
275 RESPONSE TO ABIOTIC STIMULUS 27 1024 1.493e-10 2.52e-09
276 NEPHRON DEVELOPMENT 11 115 1.495e-10 2.52e-09
277 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE 6 14 1.522e-10 2.557e-09
278 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 25 876 1.559e-10 2.61e-09
279 PITUITARY GLAND DEVELOPMENT 8 42 1.834e-10 3.047e-09
280 CELL CELL ADHESION 21 608 1.833e-10 3.047e-09
281 ESTABLISHMENT OF CELL POLARITY 10 88 1.889e-10 3.128e-09
282 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 12 153 2.179e-10 3.596e-09
283 AXIS SPECIFICATION 10 90 2.369e-10 3.895e-09
284 AXIS ELONGATION 7 27 2.517e-10 4.123e-09
285 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 8 44 2.725e-10 4.449e-09
286 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 11 122 2.841e-10 4.623e-09
287 INNER EAR MORPHOGENESIS 10 92 2.955e-10 4.791e-09
288 ENDOCRINE SYSTEM DEVELOPMENT 11 123 3.104e-10 5.015e-09
289 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 10 93 3.294e-10 5.303e-09
290 MAMMARY GLAND DUCT MORPHOGENESIS 7 28 3.338e-10 5.356e-09
291 ORGAN INDUCTION 6 16 4.018e-10 6.425e-09
292 REGULATION OF PHOSPHATASE ACTIVITY 11 128 4.775e-10 7.609e-09
293 REGULATION OF MEMBRANE PERMEABILITY 9 70 5.13e-10 8.147e-09
294 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 11 129 5.193e-10 8.218e-09
295 CELLULAR RESPONSE TO LIPID 18 457 5.238e-10 8.262e-09
296 NEURON PROJECTION MORPHOGENESIS 17 402 5.614e-10 8.825e-09
297 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 8 48 5.682e-10 8.873e-09
298 DIGESTIVE TRACT MORPHOGENESIS 8 48 5.682e-10 8.873e-09
299 POSITIVE REGULATION OF MAP KINASE ACTIVITY 13 207 5.937e-10 9.239e-09
300 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 17 404 6.055e-10 9.392e-09
301 BRANCH ELONGATION OF AN EPITHELIUM 6 17 6.178e-10 9.551e-09
302 APPENDAGE DEVELOPMENT 12 169 6.901e-10 1.06e-08
303 LIMB DEVELOPMENT 12 169 6.901e-10 1.06e-08
304 CELL CYCLE PHASE TRANSITION 14 255 7.312e-10 1.119e-08
305 REGULATION OF ORGAN GROWTH 9 73 7.539e-10 1.146e-08
306 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 9 73 7.539e-10 1.146e-08
307 RESPONSE TO EXTERNAL STIMULUS 35 1821 9.625e-10 1.458e-08
308 ODONTOGENESIS OF DENTIN CONTAINING TOOTH 9 75 9.652e-10 1.458e-08
309 POSITIVE REGULATION OF PROTEIN IMPORT 10 104 1.004e-09 1.512e-08
310 BLOOD VESSEL MORPHOGENESIS 16 364 1.075e-09 1.614e-08
311 REGULATION OF RESPONSE TO STRESS 31 1468 1.221e-09 1.827e-08
312 DIENCEPHALON DEVELOPMENT 9 77 1.227e-09 1.83e-08
313 SEX DIFFERENTIATION 14 266 1.266e-09 1.882e-08
314 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 8 53 1.3e-09 1.921e-08
315 MESONEPHRIC TUBULE MORPHOGENESIS 8 53 1.3e-09 1.921e-08
316 RENAL TUBULE DEVELOPMENT 9 78 1.38e-09 2.032e-08
317 REGULATION OF MESENCHYMAL CELL PROLIFERATION 7 34 1.47e-09 2.158e-08
318 CELL PROJECTION ORGANIZATION 24 902 1.556e-09 2.276e-08
319 MACROMOLECULAR COMPLEX DISASSEMBLY 12 182 1.615e-09 2.356e-08
320 REGULATION OF NEURON DIFFERENTIATION 19 554 1.664e-09 2.411e-08
321 MACROMOLECULAR COMPLEX ASSEMBLY 30 1398 1.659e-09 2.411e-08
322 MUSCLE STRUCTURE DEVELOPMENT 17 432 1.674e-09 2.418e-08
323 CRANIAL SKELETAL SYSTEM DEVELOPMENT 8 55 1.768e-09 2.547e-08
324 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 13 228 1.937e-09 2.781e-08
325 REGULATION OF JUN KINASE ACTIVITY 9 81 1.943e-09 2.782e-08
326 EAR MORPHOGENESIS 10 112 2.088e-09 2.981e-08
327 NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT 7 36 2.258e-09 3.203e-08
328 NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 7 36 2.258e-09 3.203e-08
329 COCHLEA MORPHOGENESIS 6 21 2.654e-09 3.754e-08
330 EMBRYONIC PATTERN SPECIFICATION 8 58 2.74e-09 3.863e-08
331 ESTABLISHMENT OR MAINTENANCE OF APICAL BASAL CELL POLARITY 7 37 2.771e-09 3.883e-08
332 ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY 7 37 2.771e-09 3.883e-08
333 CARDIAC SEPTUM DEVELOPMENT 9 85 3.003e-09 4.196e-08
334 ACTIVIN RECEPTOR SIGNALING PATHWAY 6 22 3.631e-09 5.058e-08
335 IMMUNE SYSTEM DEVELOPMENT 19 582 3.732e-09 5.183e-08
336 POSITIVE REGULATION OF STEM CELL PROLIFERATION 8 61 4.144e-09 5.739e-08
337 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 10 121 4.454e-09 6.149e-08
338 SOMITOGENESIS 8 62 4.733e-09 6.516e-08
339 REGULATION OF JNK CASCADE 11 159 4.816e-09 6.61e-08
340 APICAL JUNCTION ASSEMBLY 7 40 4.94e-09 6.761e-08
341 POSITIVE REGULATION OF JUN KINASE ACTIVITY 8 63 5.394e-09 7.36e-08
342 WOUND HEALING 17 470 5.914e-09 8.046e-08
343 MITOCHONDRIAL MEMBRANE ORGANIZATION 9 92 6.108e-09 8.286e-08
344 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 6 24 6.483e-09 8.744e-08
345 REGULATION OF PROTEIN PHOSPHATASE TYPE 2A ACTIVITY 6 24 6.483e-09 8.744e-08
346 NEPHRON EPITHELIUM DEVELOPMENT 9 93 6.727e-09 9.023e-08
347 MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 5 12 6.729e-09 9.023e-08
348 MEMBRANE ORGANIZATION 23 899 7.522e-09 1.006e-07
349 POSITIVE REGULATION OF NEURON DIFFERENTIATION 14 306 7.647e-09 1.02e-07
350 RESPONSE TO ALCOHOL 15 362 8.205e-09 1.091e-07
351 POSITIVE REGULATION OF LOCOMOTION 16 420 8.298e-09 1.1e-07
352 BETA CATENIN TCF COMPLEX ASSEMBLY 7 43 8.407e-09 1.111e-07
353 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 13 258 8.602e-09 1.132e-07
354 SKIN DEVELOPMENT 12 211 8.614e-09 1.132e-07
355 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 22 829 8.66e-09 1.135e-07
356 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 20 684 8.986e-09 1.175e-07
357 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 6 26 1.098e-08 1.427e-07
358 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 6 26 1.098e-08 1.427e-07
359 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 7 46 1.375e-08 1.782e-07
360 RESPONSE TO WOUNDING 18 563 1.381e-08 1.783e-07
361 EYE MORPHOGENESIS 10 136 1.383e-08 1.783e-07
362 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 6 27 1.404e-08 1.805e-07
363 NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 8 71 1.421e-08 1.822e-07
364 REGULATION OF PROTEIN STABILITY 12 221 1.446e-08 1.848e-07
365 CELL PART MORPHOGENESIS 19 633 1.45e-08 1.849e-07
366 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 9 102 1.528e-08 1.943e-07
367 REGULATION OF CYTOSKELETON ORGANIZATION 17 502 1.564e-08 1.983e-07
368 CELL CYCLE G2 M PHASE TRANSITION 10 138 1.592e-08 2.013e-07
369 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 5 14 1.684e-08 2.123e-07
370 VENTRICULAR SEPTUM MORPHOGENESIS 6 28 1.778e-08 2.23e-07
371 DOPAMINERGIC NEURON DIFFERENTIATION 6 28 1.778e-08 2.23e-07
372 CELL CELL JUNCTION ASSEMBLY 8 74 1.982e-08 2.479e-07
373 BIOLOGICAL ADHESION 24 1032 2.125e-08 2.651e-07
374 CARDIAC SEPTUM MORPHOGENESIS 7 49 2.173e-08 2.703e-07
375 STEM CELL DIVISION 6 29 2.23e-08 2.767e-07
376 CARDIAC CHAMBER DEVELOPMENT 10 144 2.394e-08 2.963e-07
377 EPITHELIAL CELL DEVELOPMENT 11 186 2.473e-08 3.047e-07
378 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 13 282 2.476e-08 3.047e-07
379 ESTABLISHMENT OR MAINTENANCE OF EPITHELIAL CELL APICAL BASAL POLARITY 6 30 2.774e-08 3.405e-07
380 SOMITE DEVELOPMENT 8 78 3.02e-08 3.698e-07
381 MALE SEX DIFFERENTIATION 10 148 3.111e-08 3.8e-07
382 TAXIS 16 464 3.341e-08 4.061e-07
383 BONE MORPHOGENESIS 8 79 3.343e-08 4.061e-07
384 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 7 53 3.819e-08 4.627e-07
385 ENDOCARDIAL CUSHION DEVELOPMENT 6 32 4.19e-08 5.051e-07
386 BICELLULAR TIGHT JUNCTION ASSEMBLY 6 32 4.19e-08 5.051e-07
387 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 9 115 4.384e-08 5.271e-07
388 CELL CYCLE ARREST 10 154 4.542e-08 5.447e-07
389 NEGATIVE REGULATION OF MITOTIC CELL CYCLE 11 199 4.954e-08 5.926e-07
390 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 9 117 5.095e-08 6.048e-07
391 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 9 117 5.095e-08 6.048e-07
392 POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT 6 33 5.095e-08 6.048e-07
393 NEGATIVE REGULATION OF STEM CELL PROLIFERATION 5 17 5.127e-08 6.062e-07
394 BONE DEVELOPMENT 10 156 5.133e-08 6.062e-07
395 CELL CELL SIGNALING 20 767 5.975e-08 7.039e-07
396 ORGAN FORMATION 6 34 6.155e-08 7.233e-07
397 EPIDERMIS DEVELOPMENT 12 253 6.44e-08 7.548e-07
398 NEURON PROJECTION GUIDANCE 11 205 6.712e-08 7.847e-07
399 LEUKOCYTE CELL CELL ADHESION 12 255 7.019e-08 8.185e-07
400 EPITHELIAL CELL PROLIFERATION 8 89 8.59e-08 9.993e-07
401 POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION 10 167 9.77e-08 1.134e-06
402 POSITIVE REGULATION OF CELL ADHESION 14 376 1.004e-07 1.162e-06
403 EMBRYONIC DIGIT MORPHOGENESIS 7 61 1.037e-07 1.195e-06
404 POSITIVE REGULATION OF BINDING 9 127 1.038e-07 1.195e-06
405 RESPONSE TO ACID CHEMICAL 13 319 1.047e-07 1.201e-06
406 REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 6 37 1.048e-07 1.201e-06
407 REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION 9 128 1.11e-07 1.269e-06
408 NEGATIVE REGULATION OF CELL GROWTH 10 170 1.155e-07 1.317e-06
409 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 20 799 1.159e-07 1.319e-06
410 RESPONSE TO ESTROGEN 11 218 1.254e-07 1.423e-06
411 TRACHEA DEVELOPMENT 5 20 1.265e-07 1.426e-06
412 BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS 5 20 1.265e-07 1.426e-06
413 NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 5 20 1.265e-07 1.426e-06
414 NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 8 95 1.433e-07 1.611e-06
415 COCHLEA DEVELOPMENT 6 39 1.456e-07 1.632e-06
416 CELLULAR RESPONSE TO ACID CHEMICAL 10 175 1.515e-07 1.691e-06
417 GLIOGENESIS 10 175 1.515e-07 1.691e-06
418 NEGATIVE REGULATION OF CELL ADHESION 11 223 1.576e-07 1.755e-06
419 NEGATIVE REGULATION OF ORGAN GROWTH 5 21 1.653e-07 1.835e-06
420 SINGLE ORGANISM CELLULAR LOCALIZATION 21 898 1.68e-07 1.862e-06
421 NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 6 40 1.704e-07 1.883e-06
422 NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 9 135 1.755e-07 1.935e-06
423 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 7 66 1.804e-07 1.98e-06
424 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 7 66 1.804e-07 1.98e-06
425 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 8 99 1.977e-07 2.159e-06
426 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 8 99 1.977e-07 2.159e-06
427 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 6 41 1.986e-07 2.164e-06
428 CIRCADIAN RHYTHM 9 137 1.991e-07 2.164e-06
429 NEURON FATE COMMITMENT 7 67 2.004e-07 2.174e-06
430 ENDOCARDIAL CUSHION MORPHOGENESIS 5 22 2.128e-07 2.297e-06
431 SOMATIC STEM CELL DIVISION 5 22 2.128e-07 2.297e-06
432 REGULATION OF DNA METABOLIC PROCESS 13 340 2.181e-07 2.349e-06
433 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 7 68 2.223e-07 2.388e-06
434 LYMPHOCYTE ACTIVATION 13 342 2.333e-07 2.501e-06
435 CELL MOTILITY 20 835 2.349e-07 2.507e-06
436 LOCALIZATION OF CELL 20 835 2.349e-07 2.507e-06
437 NEGATIVE REGULATION OF OSSIFICATION 7 69 2.461e-07 2.62e-06
438 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 14 406 2.559e-07 2.719e-06
439 REGULATION OF CIRCADIAN RHYTHM 8 103 2.689e-07 2.85e-06
440 REGULATION OF METANEPHROS DEVELOPMENT 5 23 2.706e-07 2.861e-06
441 NEURAL PRECURSOR CELL PROLIFERATION 7 70 2.72e-07 2.87e-06
442 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 9 143 2.87e-07 3.021e-06
443 CARDIAC CHAMBER MORPHOGENESIS 8 104 2.898e-07 3.044e-06
444 REGULATION OF CELLULAR COMPONENT BIOGENESIS 19 767 2.925e-07 3.065e-06
445 ENDODERM DEVELOPMENT 7 71 3.002e-07 3.139e-06
446 LEUKOCYTE DIFFERENTIATION 12 292 3.039e-07 3.17e-06
447 SYNAPSE ORGANIZATION 9 145 3.23e-07 3.362e-06
448 LEUKOCYTE ACTIVATION 14 414 3.24e-07 3.365e-06
449 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 10 191 3.417e-07 3.541e-06
450 LUNG MORPHOGENESIS 6 45 3.524e-07 3.636e-06
451 ENDOCHONDRAL BONE MORPHOGENESIS 6 45 3.524e-07 3.636e-06
452 POSITIVE REGULATION OF PROTEIN BINDING 7 73 3.64e-07 3.739e-06
453 PANCREAS DEVELOPMENT 7 73 3.64e-07 3.739e-06
454 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 6 46 4.032e-07 4.133e-06
455 REGULATION OF CELL CYCLE PROCESS 16 558 4.094e-07 4.187e-06
456 LENS FIBER CELL DIFFERENTIATION 5 25 4.229e-07 4.297e-06
457 FOREBRAIN REGIONALIZATION 5 25 4.229e-07 4.297e-06
458 POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 5 25 4.229e-07 4.297e-06
459 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 12 303 4.508e-07 4.57e-06
460 REGULATION OF PROTEOLYSIS 18 711 4.534e-07 4.586e-06
461 POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 4 11 4.638e-07 4.682e-06
462 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 8 111 4.789e-07 4.824e-06
463 NEGATIVE REGULATION OF KINASE ACTIVITY 11 250 4.943e-07 4.967e-06
464 RESPONSE TO STEROID HORMONE 15 497 5.099e-07 5.114e-06
465 ANTERIOR POSTERIOR AXIS SPECIFICATION 6 48 5.229e-07 5.233e-06
466 REGULATION OF BMP SIGNALING PATHWAY 7 77 5.263e-07 5.255e-06
467 OVULATION CYCLE 8 113 5.493e-07 5.473e-06
468 REGULATION OF ACTIN FILAMENT BASED PROCESS 12 312 6.149e-07 6.114e-06
469 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 14 437 6.195e-07 6.146e-06
470 RESPONSE TO LITHIUM ION 5 27 6.363e-07 6.299e-06
471 RESPONSE TO HORMONE 20 893 6.772e-07 6.69e-06
472 ANATOMICAL STRUCTURE REGRESSION 4 12 6.924e-07 6.797e-06
473 REGULATION OF MACROPHAGE CYTOKINE PRODUCTION 4 12 6.924e-07 6.797e-06
474 TRACHEA MORPHOGENESIS 4 12 6.924e-07 6.797e-06
475 METANEPHROS DEVELOPMENT 7 81 7.455e-07 7.303e-06
476 POSITIVE REGULATION OF FAT CELL DIFFERENTIATION 6 51 7.558e-07 7.388e-06
477 CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER 5 28 7.707e-07 7.518e-06
478 REGULATION OF DNA REPLICATION 9 161 7.818e-07 7.595e-06
479 LYMPHOCYTE DIFFERENTIATION 10 209 7.815e-07 7.595e-06
480 POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS 11 263 8.154e-07 7.904e-06
481 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 8 122 9.864e-07 9.542e-06
482 GDP METABOLIC PROCESS 4 13 9.953e-07 9.588e-06
483 MESENCHYMAL CELL PROLIFERATION 4 13 9.953e-07 9.588e-06
484 T CELL DIFFERENTIATION 8 123 1.05e-06 1.009e-05
485 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 10 216 1.055e-06 1.012e-05
486 REGULATION OF CELL GROWTH 13 391 1.059e-06 1.014e-05
487 VENTRICULAR SEPTUM DEVELOPMENT 6 54 1.067e-06 1.02e-05
488 REGULATION OF PROTEIN CATABOLIC PROCESS 13 393 1.121e-06 1.069e-05
489 REGULATION OF CELL DIVISION 11 272 1.134e-06 1.079e-05
490 REGULATION OF MITOCHONDRION ORGANIZATION 10 218 1.147e-06 1.089e-05
491 POSITIVE REGULATION OF CELL CYCLE 12 332 1.182e-06 1.12e-05
492 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 8 126 1.26e-06 1.192e-05
493 OVULATION CYCLE PROCESS 7 88 1.313e-06 1.239e-05
494 MITOTIC CELL CYCLE 18 766 1.323e-06 1.246e-05
495 EMBRYONIC SKELETAL JOINT DEVELOPMENT 4 14 1.387e-06 1.303e-05
496 REGULATION OF MITOTIC CELL CYCLE 14 468 1.394e-06 1.308e-05
497 ACTIVATION OF PROTEIN KINASE ACTIVITY 11 279 1.453e-06 1.361e-05
498 CIRCADIAN REGULATION OF GENE EXPRESSION 6 57 1.477e-06 1.377e-05
499 REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 6 57 1.477e-06 1.377e-05
500 ENDOTHELIUM DEVELOPMENT 7 90 1.529e-06 1.42e-05
501 REGULATION OF GLIOGENESIS 7 90 1.529e-06 1.42e-05
502 MITOCHONDRIAL TRANSPORT 9 177 1.723e-06 1.594e-05
503 TELENCEPHALON DEVELOPMENT 10 228 1.72e-06 1.594e-05
504 EMBRYONIC AXIS SPECIFICATION 5 33 1.815e-06 1.673e-05
505 VASCULOGENESIS 6 59 1.815e-06 1.673e-05
506 REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 6 60 2.007e-06 1.845e-05
507 REGULATION OF VASCULATURE DEVELOPMENT 10 233 2.091e-06 1.919e-05
508 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 12 351 2.11e-06 1.932e-05
509 BRAIN MORPHOGENESIS 5 34 2.118e-06 1.936e-05
510 ANGIOGENESIS 11 293 2.336e-06 2.132e-05
511 MUSCLE CELL DIFFERENTIATION 10 237 2.435e-06 2.218e-05
512 POSITIVE REGULATION OF DNA METABOLIC PROCESS 9 185 2.482e-06 2.256e-05
513 NEGATIVE REGULATION OF CELL CELL ADHESION 8 138 2.501e-06 2.26e-05
514 PROTEIN LOCALIZATION TO SYNAPSE 4 16 2.497e-06 2.26e-05
515 APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS 4 16 2.497e-06 2.26e-05
516 POSITIVE REGULATION OF GROWTH 10 238 2.529e-06 2.28e-05
517 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 17 724 2.709e-06 2.438e-05
518 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 7 98 2.717e-06 2.44e-05
519 CARDIAC MUSCLE TISSUE DEVELOPMENT 8 140 2.785e-06 2.497e-05
520 HEAD MORPHOGENESIS 5 36 2.84e-06 2.542e-05
521 POSITIVE REGULATION OF PROTEOLYSIS 12 363 2.984e-06 2.665e-05
522 POSITIVE REGULATION OF CELL CELL ADHESION 10 243 3.045e-06 2.714e-05
523 PROTEIN DEPHOSPHORYLATION 9 190 3.09e-06 2.749e-05
524 EPIDERMAL CELL DIFFERENTIATION 8 142 3.097e-06 2.75e-05
525 CELLULAR RESPONSE TO LITHIUM ION 4 17 3.249e-06 2.869e-05
526 ESTABLISHMENT OF TISSUE POLARITY 4 17 3.249e-06 2.869e-05
527 NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 4 17 3.249e-06 2.869e-05
528 NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 5 37 3.268e-06 2.88e-05
529 CAMERA TYPE EYE MORPHOGENESIS 7 101 3.326e-06 2.925e-05
530 POSITIVE REGULATION OF HYDROLASE ACTIVITY 19 905 3.432e-06 3.013e-05
531 NEGATIVE REGULATION OF MAPK CASCADE 8 145 3.619e-06 3.171e-05
532 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 7 103 3.792e-06 3.317e-05
533 RESPONSE TO ESTRADIOL 8 146 3.809e-06 3.325e-05
534 RESPONSE TO OXYGEN LEVELS 11 311 4.142e-06 3.609e-05
535 PERICARDIUM DEVELOPMENT 4 18 4.158e-06 3.609e-05
536 KIDNEY MESENCHYME DEVELOPMENT 4 18 4.158e-06 3.609e-05
537 PEPTIDYL SERINE MODIFICATION 8 148 4.215e-06 3.652e-05
538 CELLULAR COMPONENT DISASSEMBLY 14 515 4.235e-06 3.663e-05
539 GLANDULAR EPITHELIAL CELL DIFFERENTIATION 5 39 4.273e-06 3.689e-05
540 SYNAPSE ASSEMBLY 6 69 4.59e-06 3.955e-05
541 MUSCLE ORGAN MORPHOGENESIS 6 70 4.995e-06 4.296e-05
542 REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 4 19 5.241e-06 4.475e-05
543 ENTRAINMENT OF CIRCADIAN CLOCK BY PHOTOPERIOD 4 19 5.241e-06 4.475e-05
544 REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 4 19 5.241e-06 4.475e-05
545 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 4 19 5.241e-06 4.475e-05
546 SKIN EPIDERMIS DEVELOPMENT 6 71 5.428e-06 4.626e-05
547 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 5 41 5.507e-06 4.667e-05
548 LUNG ALVEOLUS DEVELOPMENT 5 41 5.507e-06 4.667e-05
549 RECEPTOR CLUSTERING 5 41 5.507e-06 4.667e-05
550 NEGATIVE REGULATION OF LOCOMOTION 10 263 6.135e-06 5.191e-05
551 POSTTRANSCRIPTIONAL GENE SILENCING 5 42 6.22e-06 5.243e-05
552 EPITHELIAL CELL MORPHOGENESIS 5 42 6.22e-06 5.243e-05
553 EMBRYONIC HEART TUBE DEVELOPMENT 6 73 6.386e-06 5.373e-05
554 TONGUE DEVELOPMENT 4 20 6.52e-06 5.466e-05
555 GMP METABOLIC PROCESS 4 20 6.52e-06 5.466e-05
556 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 9 209 6.716e-06 5.62e-05
557 NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION 5 43 7.003e-06 5.85e-05
558 BODY MORPHOGENESIS 5 44 7.862e-06 6.556e-05
559 APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 4 21 8.015e-06 6.659e-05
560 NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 4 21 8.015e-06 6.659e-05
561 FEMALE SEX DIFFERENTIATION 7 116 8.345e-06 6.922e-05
562 THYMOCYTE AGGREGATION 5 45 8.801e-06 7.26e-05
563 T CELL DIFFERENTIATION IN THYMUS 5 45 8.801e-06 7.26e-05
564 REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 5 45 8.801e-06 7.26e-05
565 MUSCLE TISSUE DEVELOPMENT 10 275 9.071e-06 7.47e-05
566 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 7 118 9.339e-06 7.678e-05
567 REGULATION OF EPITHELIAL CELL MIGRATION 8 166 9.82e-06 8.044e-05
568 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 8 166 9.82e-06 8.044e-05
569 NEGATIVE REGULATION OF PROTEIN BINDING 6 79 1.011e-05 8.271e-05
570 REGULATION OF CELL PROJECTION ORGANIZATION 14 558 1.053e-05 8.597e-05
571 LOCALIZATION WITHIN MEMBRANE 7 122 1.162e-05 9.472e-05
572 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 4 23 1.174e-05 9.537e-05
573 POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS 4 23 1.174e-05 9.537e-05
574 POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 5 48 1.215e-05 9.85e-05
575 REGULATION OF CATABOLIC PROCESS 16 731 1.313e-05 0.0001063
576 REGULATION OF CELL SUBSTRATE ADHESION 8 173 1.327e-05 0.0001072
577 HAIR CYCLE 6 83 1.346e-05 0.0001082
578 MOLTING CYCLE 6 83 1.346e-05 0.0001082
579 REGULATION OF STEROID BIOSYNTHETIC PROCESS 5 49 1.346e-05 0.0001082
580 PHOTOPERIODISM 4 24 1.402e-05 0.0001121
581 RESPONSE TO STEROL 4 24 1.402e-05 0.0001121
582 REGULATION OF ODONTOGENESIS 4 24 1.402e-05 0.0001121
583 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 6 84 1.442e-05 0.0001151
584 FACE DEVELOPMENT 5 50 1.489e-05 0.0001186
585 REGULATION OF LEUKOCYTE DIFFERENTIATION 9 232 1.551e-05 0.0001232
586 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 9 232 1.551e-05 0.0001232
587 POSITIVE REGULATION OF DNA REPLICATION 6 86 1.651e-05 0.0001309
588 REGULATION OF REPRODUCTIVE PROCESS 7 129 1.673e-05 0.0001324
589 RESPONSE TO DRUG 12 431 1.687e-05 0.0001333
590 REGULATION OF CHEMOTAXIS 8 180 1.769e-05 0.0001395
591 CYTOSKELETON ORGANIZATION 17 838 1.841e-05 0.0001449
592 PROTEIN STABILIZATION 7 131 1.849e-05 0.0001451
593 NEGATIVE REGULATION OF BINDING 7 131 1.849e-05 0.0001451
594 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 6 88 1.884e-05 0.0001476
595 DEVELOPMENTAL PROGRAMMED CELL DEATH 4 26 1.954e-05 0.0001515
596 POSITIVE REGULATION OF CELL DIVISION 7 132 1.942e-05 0.0001515
597 ENTRAINMENT OF CIRCADIAN CLOCK 4 26 1.954e-05 0.0001515
598 MAINTENANCE OF CELL NUMBER 7 132 1.942e-05 0.0001515
599 REGULATION OF HORMONE METABOLIC PROCESS 4 26 1.954e-05 0.0001515
600 REGULATION OF CELL FATE COMMITMENT 4 26 1.954e-05 0.0001515
601 REGULATION OF CELL MATRIX ADHESION 6 90 2.142e-05 0.0001659
602 REGULATION OF MICROTUBULE BASED PROCESS 9 243 2.238e-05 0.000173
603 REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 4 27 2.283e-05 0.0001762
604 NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 7 136 2.356e-05 0.0001815
605 PROTEIN LOCALIZATION TO MEMBRANE 11 376 2.451e-05 0.0001885
606 HINDBRAIN DEVELOPMENT 7 137 2.471e-05 0.0001897
607 RESPONSE TO NITROGEN COMPOUND 17 859 2.522e-05 0.0001933
608 REGULATION OF DNA BINDING 6 93 2.583e-05 0.0001977
609 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 5 56 2.605e-05 0.0001987
610 OUTFLOW TRACT MORPHOGENESIS 5 56 2.605e-05 0.0001987
611 GASTRULATION WITH MOUTH FORMING SECOND 4 28 2.651e-05 0.0002009
612 REGULATION OF NEUROBLAST PROLIFERATION 4 28 2.651e-05 0.0002009
613 MORPHOGENESIS OF A POLARIZED EPITHELIUM 4 28 2.651e-05 0.0002009
614 METANEPHROS MORPHOGENESIS 4 28 2.651e-05 0.0002009
615 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 4 29 3.06e-05 0.0002303
616 NEGATIVE REGULATION OF TRANSPORT 12 458 3.064e-05 0.0002303
617 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 4 29 3.06e-05 0.0002303
618 REGULATION OF OLIGODENDROCYTE DIFFERENTIATION 4 29 3.06e-05 0.0002303
619 NEUROBLAST PROLIFERATION 4 29 3.06e-05 0.0002303
620 REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 6 97 3.281e-05 0.0002462
621 CELLULAR RESPONSE TO STRESS 24 1565 3.349e-05 0.0002509
622 REGULATION OF GLIAL CELL DIFFERENTIATION 5 59 3.363e-05 0.0002516
623 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 6 98 3.477e-05 0.0002597
624 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 8 200 3.764e-05 0.0002807
625 REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH 3 11 3.791e-05 0.0002822
626 POSITIVE REGULATION OF CATABOLIC PROCESS 11 395 3.842e-05 0.0002856
627 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 6 100 3.898e-05 0.0002893
628 POSITIVE REGULATION OF CELL GROWTH 7 148 4.056e-05 0.0003005
629 REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 6 101 4.123e-05 0.000305
630 SALIVARY GLAND DEVELOPMENT 4 32 4.566e-05 0.0003367
631 POSITIVE REGULATION OF BMP SIGNALING PATHWAY 4 32 4.566e-05 0.0003367
632 REGULATION OF MUSCLE CELL DIFFERENTIATION 7 152 4.807e-05 0.0003539
633 NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH 3 12 5.032e-05 0.0003681
634 REGULATION OF THYMOCYTE APOPTOTIC PROCESS 3 12 5.032e-05 0.0003681
635 HEART FORMATION 3 12 5.032e-05 0.0003681
636 NEGATIVE REGULATION OF HEART GROWTH 3 12 5.032e-05 0.0003681
637 REGULATION OF T CELL APOPTOTIC PROCESS 4 33 5.171e-05 0.0003759
638 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 4 33 5.171e-05 0.0003759
639 REGULATION OF NEURON PROJECTION DEVELOPMENT 11 408 5.148e-05 0.0003759
640 EMBRYONIC EYE MORPHOGENESIS 4 33 5.171e-05 0.0003759
641 REGULATION OF CYTOKINE PRODUCTION 13 563 5.221e-05 0.000379
642 REGULATION OF IMMUNE SYSTEM PROCESS 22 1403 5.407e-05 0.000391
643 CARDIAC VENTRICLE DEVELOPMENT 6 106 5.411e-05 0.000391
644 FAT CELL DIFFERENTIATION 6 106 5.411e-05 0.000391
645 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 7 156 5.669e-05 0.0004083
646 PROTEIN LOCALIZATION TO NUCLEUS 7 156 5.669e-05 0.0004083
647 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 9 274 5.707e-05 0.0004104
648 NEURAL NUCLEUS DEVELOPMENT 5 66 5.797e-05 0.0004163
649 LUNG EPITHELIUM DEVELOPMENT 4 34 5.832e-05 0.0004175
650 PROTEIN DESTABILIZATION 4 34 5.832e-05 0.0004175
651 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 8 213 5.874e-05 0.0004199
652 ORGANELLE LOCALIZATION 11 415 5.997e-05 0.000428
653 HORMONE MEDIATED SIGNALING PATHWAY 7 158 6.145e-05 0.0004379
654 POSITIVE REGULATION OF NEURON DEATH 5 67 6.234e-05 0.0004428
655 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 5 67 6.234e-05 0.0004428
656 NEURONAL STEM CELL DIVISION 3 13 6.512e-05 0.0004563
657 NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION 3 13 6.512e-05 0.0004563
658 TYPE B PANCREATIC CELL DEVELOPMENT 3 13 6.512e-05 0.0004563
659 POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS 3 13 6.512e-05 0.0004563
660 REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT 3 13 6.512e-05 0.0004563
661 NEUROBLAST DIVISION 3 13 6.512e-05 0.0004563
662 REGULATION OF CELL FATE SPECIFICATION 3 13 6.512e-05 0.0004563
663 MESODERMAL CELL FATE COMMITMENT 3 13 6.512e-05 0.0004563
664 POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 3 13 6.512e-05 0.0004563
665 MICROTUBULE CYTOSKELETON ORGANIZATION 10 348 6.75e-05 0.0004723
666 REGENERATION 7 161 6.92e-05 0.0004835
667 REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 4 36 7.337e-05 0.0005118
668 REGULATION OF NUCLEAR DIVISION 7 163 7.48e-05 0.000521
669 DEPHOSPHORYLATION 9 286 7.929e-05 0.0005515
670 IMMUNE SYSTEM PROCESS 27 1984 7.981e-05 0.0005543
671 REGULATION OF ENDOTHELIAL CELL MIGRATION 6 114 8.123e-05 0.0005633
672 HINDLIMB MORPHOGENESIS 4 37 8.186e-05 0.0005645
673 RENAL VESICLE DEVELOPMENT 3 14 8.25e-05 0.0005645
674 METANEPHRIC MESENCHYME DEVELOPMENT 3 14 8.25e-05 0.0005645
675 CONVERGENT EXTENSION 3 14 8.25e-05 0.0005645
676 CELL FATE SPECIFICATION 5 71 8.238e-05 0.0005645
677 CRANIOFACIAL SUTURE MORPHOGENESIS 3 14 8.25e-05 0.0005645
678 ADENOHYPOPHYSIS DEVELOPMENT 3 14 8.25e-05 0.0005645
679 REGULATION OF GTPASE ACTIVITY 14 673 8.161e-05 0.0005645
680 RESPONSE TO LAMINAR FLUID SHEAR STRESS 3 14 8.25e-05 0.0005645
681 ENERGY RESERVE METABOLIC PROCESS 5 72 8.809e-05 0.000601
682 ENDOTHELIAL CELL DIFFERENTIATION 5 72 8.809e-05 0.000601
683 MULTICELLULAR ORGANISM REPRODUCTION 15 768 9.086e-05 0.000619
684 REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 4 38 9.105e-05 0.0006194
685 NEGATIVE REGULATION OF MAP KINASE ACTIVITY 5 73 9.41e-05 0.0006373
686 HIPPOCAMPUS DEVELOPMENT 5 73 9.41e-05 0.0006373
687 REGULATION OF PLASMA MEMBRANE ORGANIZATION 5 73 9.41e-05 0.0006373
688 REGULATION OF GENE EXPRESSION EPIGENETIC 8 229 9.742e-05 0.0006589
689 ESTABLISHMENT OF LOCALIZATION IN CELL 24 1676 9.892e-05 0.0006681
690 REGULATION OF STEROID METABOLIC PROCESS 5 74 0.0001004 0.0006772
691 REGULATION OF AXON GUIDANCE 4 39 0.000101 0.0006799
692 POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 3 15 0.0001026 0.0006833
693 MESENCHYMAL TO EPITHELIAL TRANSITION 3 15 0.0001026 0.0006833
694 NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS 3 15 0.0001026 0.0006833
695 REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 3 15 0.0001026 0.0006833
696 ENDOCARDIAL CUSHION FORMATION 3 15 0.0001026 0.0006833
697 REGULATION OF MESODERM DEVELOPMENT 3 15 0.0001026 0.0006833
698 REGULATION OF CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS 3 15 0.0001026 0.0006833
699 POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS 3 15 0.0001026 0.0006833
700 NEURAL CREST CELL DIFFERENTIATION 5 75 0.0001071 0.0007116
701 POSITIVE REGULATION OF CELL MATRIX ADHESION 4 40 0.0001116 0.0007411
702 NEGATIVE REGULATION OF DEPHOSPHORYLATION 5 77 0.0001213 0.0008031
703 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 5 77 0.0001213 0.0008031
704 PROSTATE GLAND DEVELOPMENT 4 41 0.0001231 0.0008138
705 ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY 3 16 0.0001258 0.0008289
706 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 3 16 0.0001258 0.0008289
707 POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 4 42 0.0001354 0.0008888
708 REGULATION OF HEART GROWTH 4 42 0.0001354 0.0008888
709 GENITALIA DEVELOPMENT 4 42 0.0001354 0.0008888
710 REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS 7 181 0.0001438 0.0009427
711 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 5 80 0.0001454 0.0009519
712 MORPHOGENESIS OF AN EPITHELIAL SHEET 4 43 0.0001486 0.0009698
713 REGULATION OF POLYSACCHARIDE METABOLIC PROCESS 4 43 0.0001486 0.0009698
714 NEGATIVE REGULATION OF KIDNEY DEVELOPMENT 3 17 0.000152 0.0009824
715 NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 3 17 0.000152 0.0009824
716 POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 3 17 0.000152 0.0009824
717 DORSAL VENTRAL NEURAL TUBE PATTERNING 3 17 0.000152 0.0009824
718 REGULATION OF STEM CELL POPULATION MAINTENANCE 3 17 0.000152 0.0009824
719 MAMMARY GLAND ALVEOLUS DEVELOPMENT 3 17 0.000152 0.0009824
720 MAMMARY GLAND LOBULE DEVELOPMENT 3 17 0.000152 0.0009824
721 REGULATION OF FIBROBLAST PROLIFERATION 5 81 0.0001542 0.0009955
722 REGULATION OF HEMOPOIESIS 9 314 0.0001606 0.001035
723 LABYRINTHINE LAYER DEVELOPMENT 4 44 0.0001627 0.001047
724 POSITIVE REGULATION OF CELL CYCLE PROCESS 8 247 0.0001641 0.001054
725 REGULATION OF PROTEIN SECRETION 10 389 0.0001682 0.00108
726 EMBRYONIC PLACENTA DEVELOPMENT 5 83 0.0001731 0.001109
727 POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 6 131 0.0001746 0.001118
728 SUBSTANTIA NIGRA DEVELOPMENT 4 45 0.0001777 0.001134
729 EXOCRINE SYSTEM DEVELOPMENT 4 45 0.0001777 0.001134
730 GLANDULAR EPITHELIAL CELL DEVELOPMENT 3 18 0.0001816 0.001151
731 REGULATION OF HORMONE BIOSYNTHETIC PROCESS 3 18 0.0001816 0.001151
732 OSTEOBLAST DEVELOPMENT 3 18 0.0001816 0.001151
733 POST ANAL TAIL MORPHOGENESIS 3 18 0.0001816 0.001151
734 NOTOCHORD DEVELOPMENT 3 18 0.0001816 0.001151
735 REGULATION OF LYMPHOCYTE DIFFERENTIATION 6 132 0.000182 0.001152
736 REGULATION OF NEURON DEATH 8 252 0.0001881 0.001189
737 GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS 4 46 0.0001937 0.001223
738 NEGATIVE REGULATION OF HYDROLASE ACTIVITY 10 397 0.0001982 0.00125
739 CELL GROWTH 6 135 0.0002057 0.001295
740 POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS 7 192 0.0002069 0.001299
741 REGULATION OF NEURON APOPTOTIC PROCESS 7 192 0.0002069 0.001299
742 POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS 4 47 0.0002107 0.001319
743 POSITIVE REGULATION OF GLIOGENESIS 4 47 0.0002107 0.001319
744 RESPONSE TO INORGANIC SUBSTANCE 11 479 0.0002114 0.001322
745 GLIAL CELL DIFFERENTIATION 6 136 0.0002141 0.001337
746 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 16 926 0.0002149 0.001339
747 ENTEROENDOCRINE CELL DIFFERENTIATION 3 19 0.0002147 0.001339
748 TISSUE REMODELING 5 87 0.0002159 0.001343
749 COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT 4 48 0.0002287 0.001421
750 PLACENTA DEVELOPMENT 6 138 0.0002317 0.001437
751 POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 3 20 0.0002514 0.001555
752 CELLULAR RESPONSE TO ABIOTIC STIMULUS 8 263 0.0002513 0.001555
753 CELLULAR RESPONSE TO EXTERNAL STIMULUS 8 264 0.0002578 0.001591
754 AGING 8 264 0.0002578 0.001591
755 RESPONSE TO RADIATION 10 413 0.0002719 0.001675
756 HOMOTYPIC CELL CELL ADHESION 4 51 0.0002895 0.001782
757 REGULATION OF GENE SILENCING BY RNA 3 21 0.0002919 0.001783
758 CHONDROCYTE DEVELOPMENT 3 21 0.0002919 0.001783
759 ECTODERM DEVELOPMENT 3 21 0.0002919 0.001783
760 POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 3 21 0.0002919 0.001783
761 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 6 144 0.0002915 0.001783
762 REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING 3 21 0.0002919 0.001783
763 PROTEASOMAL PROTEIN CATABOLIC PROCESS 8 271 0.0003074 0.001874
764 SECRETION 12 588 0.0003205 0.001952
765 REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 5 95 0.0003254 0.001979
766 REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS 8 274 0.0003309 0.00201
767 CELLULAR RESPONSE TO NITROGEN COMPOUND 11 505 0.0003319 0.002014
768 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 4 53 0.000336 0.002026
769 NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 3 22 0.0003365 0.002026
770 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 4 53 0.000336 0.002026
771 DSRNA FRAGMENTATION 3 22 0.0003365 0.002026
772 EMBRYONIC PLACENTA MORPHOGENESIS 3 22 0.0003365 0.002026
773 PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA 3 22 0.0003365 0.002026
774 REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 6 148 0.0003377 0.00203
775 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 15 867 0.0003381 0.00203
776 MYELOID LEUKOCYTE DIFFERENTIATION 5 96 0.0003416 0.002048
777 MUSCLE ORGAN DEVELOPMENT 8 277 0.0003558 0.002131
778 NEGATIVE REGULATION OF REPRODUCTIVE PROCESS 4 54 0.0003612 0.002154
779 REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 4 54 0.0003612 0.002154
780 CARDIAC MUSCLE TISSUE MORPHOGENESIS 4 54 0.0003612 0.002154
781 POSITIVE REGULATION OF PROTEIN SECRETION 7 211 0.0003669 0.002186
782 POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS 5 98 0.0003757 0.002236
783 POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 3 23 0.0003852 0.002283
784 SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 3 23 0.0003852 0.002283
785 POSITIVE REGULATION OF STEROID METABOLIC PROCESS 3 23 0.0003852 0.002283
786 PALLIUM DEVELOPMENT 6 153 0.0004032 0.002384
787 TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER 6 153 0.0004032 0.002384
788 LIMBIC SYSTEM DEVELOPMENT 5 100 0.0004124 0.002435
789 KERATINOCYTE DIFFERENTIATION 5 101 0.0004318 0.002543
790 REGULATION OF EXTENT OF CELL GROWTH 5 101 0.0004318 0.002543
791 NEGATIVE REGULATION OF STEROID METABOLIC PROCESS 3 24 0.0004382 0.002571
792 EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS 3 24 0.0004382 0.002571
793 ENDOTHELIAL CELL PROLIFERATION 3 24 0.0004382 0.002571
794 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 6 156 0.0004471 0.00262
795 CELLULAR GLUCAN METABOLIC PROCESS 4 58 0.0004753 0.002778
796 GLUCAN METABOLIC PROCESS 4 58 0.0004753 0.002778
797 EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS 3 25 0.0004957 0.00288
798 LUNG CELL DIFFERENTIATION 3 25 0.0004957 0.00288
799 REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 3 25 0.0004957 0.00288
800 REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 3 25 0.0004957 0.00288
801 EPITHELIAL CELL APOPTOTIC PROCESS 3 25 0.0004957 0.00288
802 REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 4 59 0.0005074 0.002944
803 POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION 10 448 0.0005151 0.002985
804 ACTIN FILAMENT BASED PROCESS 10 450 0.0005332 0.003086
805 NEGATIVE REGULATION OF CELL DIVISION 4 60 0.000541 0.003123
806 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 4 60 0.000541 0.003123
807 NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION 3 26 0.0005578 0.003204
808 REGULATION OF MESONEPHROS DEVELOPMENT 3 26 0.0005578 0.003204
809 MESODERMAL CELL DIFFERENTIATION 3 26 0.0005578 0.003204
810 REGULATION OF P38MAPK CASCADE 3 26 0.0005578 0.003204
811 REGULATION OF T CELL DIFFERENTIATION 5 107 0.0005625 0.003227
812 POSITIVE REGULATION OF HEMOPOIESIS 6 163 0.000564 0.003232
813 OVARIAN FOLLICLE DEVELOPMENT 4 61 0.0005762 0.003298
814 REGULATION OF CELL CYCLE ARREST 5 108 0.0005869 0.003355
815 POSITIVE REGULATION OF NUCLEAR DIVISION 4 62 0.000613 0.003495
816 EMBRYONIC HEART TUBE MORPHOGENESIS 4 62 0.000613 0.003495
817 NEGATIVE REGULATION OF AXON GUIDANCE 3 27 0.0006247 0.003554
818 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS 3 27 0.0006247 0.003554
819 NEUROEPITHELIAL CELL DIFFERENTIATION 4 63 0.0006514 0.003701
820 POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 4 64 0.0006915 0.003919
821 RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS 4 64 0.0006915 0.003919
822 POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 3 28 0.0006965 0.003936
823 CELLULAR RESPONSE TO HORMONE STIMULUS 11 552 0.0006971 0.003936
824 NEGATIVE REGULATION OF DENDRITE DEVELOPMENT 3 28 0.0006965 0.003936
825 NEGATIVE REGULATION OF PROTEIN COMPLEX DISASSEMBLY 6 170 0.0007033 0.003967
826 REGULATION OF CELL SIZE 6 172 0.0007476 0.004211
827 NOTCH SIGNALING PATHWAY 5 114 0.0007503 0.004221
828 EPIDERMIS MORPHOGENESIS 3 29 0.0007733 0.00433
829 NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 3 29 0.0007733 0.00433
830 REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 3 29 0.0007733 0.00433
831 EMBRYONIC HINDLIMB MORPHOGENESIS 3 29 0.0007733 0.00433
832 SOMATIC STEM CELL POPULATION MAINTENANCE 4 66 0.0007769 0.00434
833 FOREBRAIN GENERATION OF NEURONS 4 66 0.0007769 0.00434
834 CELLULAR RESPONSE TO ALCOHOL 5 115 0.0007805 0.004355
835 REGULATION OF PEPTIDASE ACTIVITY 9 392 0.000807 0.004497
836 POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION 6 175 0.0008181 0.004553
837 RESPONSE TO CORTICOSTEROID 6 176 0.0008427 0.004684
838 SPECIFICATION OF SYMMETRY 5 117 0.0008437 0.004684
839 PROTEIN LOCALIZATION TO CYTOSKELETON 3 30 0.0008554 0.004727
840 SMOOTH MUSCLE CELL DIFFERENTIATION 3 30 0.0008554 0.004727
841 POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 3 30 0.0008554 0.004727
842 MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 3 30 0.0008554 0.004727
843 REGULATION OF CELL JUNCTION ASSEMBLY 4 68 0.0008695 0.004794
844 ORGAN GROWTH 4 68 0.0008695 0.004794
845 REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION 6 178 0.0008937 0.004921
846 POSITIVE REGULATION OF AXONOGENESIS 4 69 0.0009186 0.005052
847 REGULATION OF CELL ACTIVATION 10 484 0.0009316 0.005118
848 POSITIVE REGULATION OF CHEMOTAXIS 5 120 0.0009455 0.005188
849 SECRETION BY CELL 10 486 0.0009611 0.005267
850 REGULATION OF PROTEIN KINASE B SIGNALING 5 121 0.0009814 0.005372
851 RESPONSE TO KETONE 6 182 0.001003 0.005482
852 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING 4 71 0.001023 0.005578
853 ADHERENS JUNCTION ORGANIZATION 4 71 0.001023 0.005578
854 NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 3 32 0.001036 0.005622
855 POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION 3 32 0.001036 0.005622
856 PROTEIN TARGETING 9 406 0.001032 0.005622
857 PATTERNING OF BLOOD VESSELS 3 32 0.001036 0.005622
858 CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM 7 252 0.001048 0.005684
859 RESPONSE TO VITAMIN D 3 33 0.001134 0.006141
860 STEROID HORMONE MEDIATED SIGNALING PATHWAY 5 125 0.001135 0.006141
861 RESPONSE TO METAL ION 8 333 0.001183 0.006391
862 MYELOID CELL DIFFERENTIATION 6 189 0.001218 0.006572
863 RESPONSE TO FLUID SHEAR STRESS 3 34 0.001238 0.006652
864 HEART VALVE DEVELOPMENT 3 34 0.001238 0.006652
865 NEGATIVE REGULATION OF MITOTIC NUCLEAR DIVISION 3 34 0.001238 0.006652
866 NEURAL TUBE PATTERNING 3 34 0.001238 0.006652
867 ARTERY DEVELOPMENT 4 75 0.001255 0.006734
868 REGULATION OF LIPID BIOSYNTHETIC PROCESS 5 128 0.001262 0.006763
869 REGULATION OF CELLULAR COMPONENT SIZE 8 337 0.001276 0.006831
870 BONE REMODELING 3 35 0.001348 0.007176
871 REGULATION OF GLYCOGEN METABOLIC PROCESS 3 35 0.001348 0.007176
872 REGULATION OF GASTRULATION 3 35 0.001348 0.007176
873 EMBRYONIC CAMERA TYPE EYE DEVELOPMENT 3 35 0.001348 0.007176
874 RESPONSE TO IRON ION 3 35 0.001348 0.007176
875 DEVELOPMENTAL MATURATION 6 193 0.001355 0.007207
876 CELL CYCLE CHECKPOINT 6 194 0.001391 0.007391
877 NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS 5 131 0.001398 0.007419
878 REGULATION OF MEMBRANE POTENTIAL 8 343 0.001427 0.00756
879 POSITIVE REGULATION OF PROTEIN ACETYLATION 3 36 0.001464 0.007722
880 POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 3 36 0.001464 0.007722
881 CORTICAL CYTOSKELETON ORGANIZATION 3 36 0.001464 0.007722
882 POSITIVE CHEMOTAXIS 3 36 0.001464 0.007722
883 CELLULAR PROTEIN COMPLEX ASSEMBLY 8 346 0.001507 0.007942
884 DENDRITE DEVELOPMENT 4 79 0.001522 0.008001
885 REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 4 79 0.001522 0.008001
886 NEGATIVE REGULATION OF GLIOGENESIS 3 37 0.001586 0.00829
887 RESPONSE TO NERVE GROWTH FACTOR 3 37 0.001586 0.00829
888 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY 3 37 0.001586 0.00829
889 GLIAL CELL MIGRATION 3 37 0.001586 0.00829
890 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 3 37 0.001586 0.00829
891 POLYSACCHARIDE METABOLIC PROCESS 4 80 0.001594 0.008306
892 POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 4 80 0.001594 0.008306
893 CELLULAR RESPONSE TO MECHANICAL STIMULUS 4 80 0.001594 0.008306
894 MICROTUBULE BASED PROCESS 10 522 0.001638 0.008525
895 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 4 81 0.001669 0.008677
896 ACTIVATION OF MAPK ACTIVITY 5 137 0.001704 0.008848
897 DNA TEMPLATED TRANSCRIPTION INITIATION 6 202 0.001709 0.008863
898 NEGATIVE REGULATION OF AXON EXTENSION 3 38 0.001714 0.00887
899 CELLULAR RESPONSE TO DSRNA 3 38 0.001714 0.00887
900 NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 4 82 0.001746 0.009028
901 MITOTIC CELL CYCLE CHECKPOINT 5 139 0.001816 0.009367
902 GENE SILENCING BY RNA 5 139 0.001816 0.009367
903 ORGAN REGENERATION 4 83 0.001826 0.009398
904 RESPONSE TO EXTRACELLULAR STIMULUS 9 441 0.001825 0.009398
905 REGULATION OF CHROMOSOME ORGANIZATION 7 278 0.001839 0.009456
906 NEGATIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 3 39 0.001848 0.009461
907 NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 3 39 0.001848 0.009461
908 REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 3 39 0.001848 0.009461
909 PLATELET AGGREGATION 3 39 0.001848 0.009461
910 NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS 4 84 0.001908 0.009756
911 RESPONSE TO LIGHT STIMULUS 7 280 0.001915 0.009782
NumGOOverlapSizeP ValueAdj. P Value
1 TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING 16 50 8.272e-24 7.685e-21
2 BETA CATENIN BINDING 18 84 4.01e-23 1.863e-20
3 FRIZZLED BINDING 14 36 2.217e-22 6.866e-20
4 RECEPTOR BINDING 44 1476 2.89e-19 6.713e-17
5 ENZYME BINDING 47 1737 5.593e-19 1.039e-16
6 PROTEIN DOMAIN SPECIFIC BINDING 30 624 1.437e-18 2.225e-16
7 WNT ACTIVATED RECEPTOR ACTIVITY 10 22 3.825e-17 5.077e-15
8 KINASE BINDING 28 606 6.706e-17 7.787e-15
9 I SMAD BINDING 8 11 3.013e-16 3.11e-14
10 SMAD BINDING 13 72 6.089e-16 5.657e-14
11 WNT PROTEIN BINDING 10 31 2.503e-15 2.114e-13
12 CYTOKINE RECEPTOR BINDING 16 271 1.381e-11 1.069e-09
13 GROWTH FACTOR ACTIVITY 13 160 2.376e-11 1.698e-09
14 GAMMA CATENIN BINDING 6 12 4.732e-11 3.14e-09
15 G PROTEIN COUPLED RECEPTOR BINDING 15 259 8.209e-11 5.084e-09
16 CYTOKINE ACTIVITY 14 219 9.859e-11 5.725e-09
17 PDZ DOMAIN BINDING 10 90 2.369e-10 1.295e-08
18 RECEPTOR SERINE THREONINE KINASE BINDING 6 15 2.524e-10 1.303e-08
19 PROTEIN DIMERIZATION ACTIVITY 28 1149 3.873e-10 1.894e-08
20 RECEPTOR SIGNALING PROTEIN ACTIVITY 12 172 8.45e-10 3.925e-08
21 UBIQUITIN LIKE PROTEIN LIGASE BINDING 14 264 1.148e-09 5.079e-08
22 PROTEIN PHOSPHATASE TYPE 2A REGULATOR ACTIVITY 6 21 2.654e-09 1.121e-07
23 MOLECULAR FUNCTION REGULATOR 29 1353 3.398e-09 1.373e-07
24 IONOTROPIC GLUTAMATE RECEPTOR BINDING 6 23 4.887e-09 1.892e-07
25 MACROMOLECULAR COMPLEX BINDING 28 1399 2.951e-08 1.097e-06
26 PROTEIN HETERODIMERIZATION ACTIVITY 16 468 3.762e-08 1.294e-06
27 RECEPTOR AGONIST ACTIVITY 5 16 3.637e-08 1.294e-06
28 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY 5 17 5.127e-08 1.701e-06
29 KINASE ACTIVITY 21 842 5.703e-08 1.827e-06
30 PROTEIN COMPLEX BINDING 22 935 7.349e-08 2.276e-06
31 IDENTICAL PROTEIN BINDING 25 1209 1.013e-07 3.037e-06
32 GLUTAMATE RECEPTOR BINDING 6 37 1.048e-07 3.042e-06
33 PROTEIN SERINE THREONINE KINASE ACTIVITY 15 445 1.244e-07 3.501e-06
34 TRANSCRIPTION FACTOR BINDING 16 524 1.763e-07 4.817e-06
35 SIGNAL TRANSDUCER ACTIVITY 30 1731 2.073e-07 5.503e-06
36 PROTEIN KINASE ACTIVITY 17 640 5.031e-07 1.298e-05
37 GUANYLATE KINASE ACTIVITY 4 12 6.924e-07 1.739e-05
38 CADHERIN BINDING 5 28 7.707e-07 1.884e-05
39 PHOSPHATASE BINDING 9 162 8.235e-07 1.962e-05
40 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 21 992 8.571e-07 1.991e-05
41 ARMADILLO REPEAT DOMAIN BINDING 4 13 9.953e-07 2.255e-05
42 PHOSPHATASE REGULATOR ACTIVITY 7 87 1.215e-06 2.686e-05
43 RECEPTOR ACTIVATOR ACTIVITY 5 32 1.548e-06 3.344e-05
44 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 7 92 1.775e-06 3.747e-05
45 PROTEIN C TERMINUS BINDING 9 186 2.595e-06 5.356e-05
46 PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY 6 64 2.945e-06 5.947e-05
47 REGULATORY REGION NUCLEIC ACID BINDING 18 818 3.335e-06 6.592e-05
48 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 22 1199 4.761e-06 9.214e-05
49 RECEPTOR REGULATOR ACTIVITY 5 45 8.801e-06 0.0001669
50 PROTEIN HOMODIMERIZATION ACTIVITY 16 722 1.127e-05 0.0002093
51 R SMAD BINDING 4 23 1.174e-05 0.0002139
52 NUCLEOTIDE KINASE ACTIVITY 4 24 1.402e-05 0.0002506
53 CORE PROMOTER PROXIMAL REGION DNA BINDING 11 371 2.167e-05 0.0003798
54 CELL ADHESION MOLECULE BINDING 8 186 2.241e-05 0.0003855
55 ENZYME REGULATOR ACTIVITY 18 959 2.877e-05 0.0004859
56 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 10 328 4.114e-05 0.000672
57 GLYCOPROTEIN BINDING 6 101 4.123e-05 0.000672
58 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 6 104 4.862e-05 0.0007788
59 CO SMAD BINDING 3 12 5.032e-05 0.0007923
60 ION CHANNEL BINDING 6 111 7.002e-05 0.001084
61 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 8 226 8.889e-05 0.001354
62 PROTEIN PHOSPHATASE BINDING 6 120 0.0001079 0.001617
63 PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR 4 40 0.0001116 0.001646
64 TRANSFORMING GROWTH FACTOR BETA BINDING 3 16 0.0001258 0.001826
65 PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 7 178 0.0001297 0.001854
66 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 5 81 0.0001542 0.002171
67 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 13 629 0.0001583 0.002194
68 NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY 4 48 0.0002287 0.003125
69 CYTOKINE BINDING 5 92 0.0002803 0.003774
70 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 12 588 0.0003205 0.004254
71 CHROMATIN BINDING 10 435 0.0004095 0.005358
72 PROTEIN PHOSPHORYLATED AMINO ACID BINDING 3 24 0.0004382 0.005654
73 PROTEIN N TERMINUS BINDING 5 103 0.0004725 0.006013
74 TRANSCRIPTION COREPRESSOR ACTIVITY 7 221 0.0004843 0.006079
75 PHOSPHOPROTEIN BINDING 4 60 0.000541 0.006702
NumGOOverlapSizeP ValueAdj. P Value
1 CELL JUNCTION 39 1151 7.401e-19 4.322e-16
2 APICAL JUNCTION COMPLEX 16 128 1.049e-16 3.063e-14
3 WNT SIGNALOSOME 8 11 3.013e-16 5.866e-14
4 CELL CELL JUNCTION 22 383 2.475e-15 3.613e-13
5 ANCHORING JUNCTION 23 489 3.848e-14 4.495e-12
6 PHOSPHATASE COMPLEX 10 48 3.376e-13 3.286e-11
7 PROTEIN PHOSPHATASE TYPE 2A COMPLEX 7 20 2.278e-11 1.9e-09
8 BETA CATENIN DESTRUCTION COMPLEX 6 14 1.522e-10 9.878e-09
9 CYTOPLASMIC VESICLE PART 21 601 1.483e-10 9.878e-09
10 EXTRACELLULAR MATRIX 17 426 1.355e-09 7.913e-08
11 CELL CELL ADHERENS JUNCTION 8 54 1.519e-09 8.017e-08
12 CELL SURFACE 22 757 1.647e-09 8.017e-08
13 CYTOSKELETON 36 1967 1.937e-09 8.703e-08
14 CELL CORTEX 13 238 3.259e-09 1.36e-07
15 NEURON PROJECTION 24 942 3.651e-09 1.421e-07
16 TRANSCRIPTION FACTOR COMPLEX 14 298 5.458e-09 1.992e-07
17 CELL PROJECTION 33 1786 8.937e-09 3.07e-07
18 INTRACELLULAR VESICLE 27 1259 1.312e-08 4.257e-07
19 NEURON PART 27 1265 1.45e-08 4.456e-07
20 VESICLE MEMBRANE 17 512 2.088e-08 5.542e-07
21 EXTRACELLULAR SPACE 28 1376 2.071e-08 5.542e-07
22 PLASMA MEMBRANE PROTEIN COMPLEX 17 510 1.972e-08 5.542e-07
23 LATERAL PLASMA MEMBRANE 7 50 2.513e-08 6.382e-07
24 CELL SUBSTRATE JUNCTION 15 398 2.896e-08 7.047e-07
25 CYTOPLASMIC REGION 13 287 3.046e-08 7.115e-07
26 ENDOCYTIC VESICLE MEMBRANE 10 152 4.011e-08 8.956e-07
27 CELL LEADING EDGE 14 350 4.141e-08 8.956e-07
28 ENDOCYTIC VESICLE 12 256 7.326e-08 1.528e-06
29 LAMELLIPODIUM 10 172 1.289e-07 2.509e-06
30 MEMBRANE REGION 24 1134 1.247e-07 2.509e-06
31 MEMBRANE MICRODOMAIN 12 288 2.621e-07 4.938e-06
32 PLASMA MEMBRANE REGION 21 929 2.945e-07 5.375e-06
33 AXON 14 418 3.637e-07 6.33e-06
34 PROTEINACEOUS EXTRACELLULAR MATRIX 13 356 3.685e-07 6.33e-06
35 CELL BODY 15 494 4.724e-07 7.882e-06
36 SOMATODENDRITIC COMPARTMENT 17 650 6.236e-07 1.012e-05
37 MICROTUBULE CYTOSKELETON 22 1068 7.154e-07 1.099e-05
38 CYTOSKELETAL PART 26 1436 7.093e-07 1.099e-05
39 SYNAPSE 18 754 1.056e-06 1.582e-05
40 PLASMA MEMBRANE RECEPTOR COMPLEX 9 175 1.568e-06 2.289e-05
41 CELL PROJECTION PART 20 946 1.651e-06 2.352e-05
42 GOLGI LUMEN 7 94 2.052e-06 2.853e-05
43 EXCITATORY SYNAPSE 9 197 4.155e-06 5.642e-05
44 POSTSYNAPSE 12 378 4.516e-06 5.994e-05
45 SYNAPSE PART 15 610 6.345e-06 8.234e-05
46 CHROMOSOME 18 880 9.113e-06 0.0001157
47 INTERCALATED DISC 5 51 1.642e-05 0.0002009
48 PLASMA MEMBRANE RAFT 6 86 1.651e-05 0.0002009
49 NEURONAL POSTSYNAPTIC DENSITY 5 53 1.986e-05 0.0002367
50 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 7 136 2.356e-05 0.0002752
51 NUCLEAR CHROMOSOME 13 523 2.445e-05 0.00028
52 DENDRITE 12 451 2.636e-05 0.0002961
53 CYTOPLASMIC MICROTUBULE 5 57 2.841e-05 0.000313
54 MICROTUBULE ORGANIZING CENTER 14 623 3.562e-05 0.0003852
55 RECEPTOR COMPLEX 10 327 4.009e-05 0.0004257
56 CELL CELL CONTACT ZONE 5 64 4.996e-05 0.0005118
57 PERINUCLEAR REGION OF CYTOPLASM 14 642 4.931e-05 0.0005118
58 CLATHRIN COATED ENDOCYTIC VESICLE 5 65 5.385e-05 0.0005422
59 BASOLATERAL PLASMA MEMBRANE 8 211 5.497e-05 0.0005441
60 CATALYTIC COMPLEX 18 1038 8.009e-05 0.0007796
61 APICAL PART OF CELL 10 361 9.143e-05 0.0008612
62 NUCLEAR CHROMATIN 9 291 9.049e-05 0.0008612
63 CELL CORTEX PART 6 119 0.000103 0.0009402
64 CHROMATIN 11 441 0.0001029 0.0009402
65 ACTIN CYTOSKELETON 11 444 0.0001092 0.0009815
66 CORTICAL CYTOSKELETON 5 81 0.0001542 0.001365
67 EXTRINSIC COMPONENT OF MEMBRANE 8 252 0.0001881 0.001639
68 MEMBRANE PROTEIN COMPLEX 17 1020 0.0002063 0.001772
69 IONOTROPIC GLUTAMATE RECEPTOR COMPLEX 4 47 0.0002107 0.001783
70 CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE 4 48 0.0002287 0.001908
71 PROTEIN KINASE COMPLEX 5 90 0.000253 0.002081
72 PLATELET ALPHA GRANULE LUMEN 4 55 0.0003876 0.003144
73 RNA POLYMERASE II TRANSCRIPTION FACTOR COMPLEX 5 101 0.0004318 0.003454
74 CLATHRIN COATED VESICLE 6 157 0.0004625 0.00365
75 CORTICAL ACTIN CYTOSKELETON 4 58 0.0004753 0.003701
76 GOLGI APPARATUS 20 1445 0.000629 0.004833
77 MYELIN SHEATH 6 168 0.000661 0.005013
78 COATED VESICLE 7 234 0.0006796 0.005088
79 CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX 3 31 0.0009427 0.006969
80 CENTROSOME 10 487 0.0009761 0.007038
81 ACTIN FILAMENT 4 70 0.0009696 0.007038
82 MICROTUBULE 9 405 0.001015 0.007109
83 HISTONE METHYLTRANSFERASE COMPLEX 4 71 0.001023 0.007109
84 SUPRAMOLECULAR FIBER 12 670 0.001012 0.007109
85 SPINDLE POLE 5 126 0.001176 0.008081
86 NUCLEAR TRANSCRIPTION FACTOR COMPLEX 5 127 0.001218 0.008273
87 PLATELET ALPHA GRANULE 4 75 0.001255 0.008423

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 Hippo_signaling_pathway_hsa04390 125 154 1.211e-297 6.299e-296
2 Wnt_signaling_pathway_hsa04310 42 146 6.017e-60 1.564e-58
3 Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 40 139 5.28e-57 9.152e-56
4 TGF_beta_signaling_pathway_hsa04350 27 84 8.676e-40 1.128e-38
5 Hippo_signaling_pathway_multiple_species_hsa04392 18 29 1.93e-33 2.008e-32
6 mTOR_signaling_pathway_hsa04150 23 151 1.09e-25 9.449e-25
7 Tight_junction_hsa04530 23 170 1.864e-24 1.385e-23
8 Adherens_junction_hsa04520 17 72 1.117e-22 7.26e-22
9 Cell_cycle_hsa04110 16 124 6.234e-17 3.602e-16
10 Cellular_senescence_hsa04218 17 160 1.803e-16 9.377e-16
11 PI3K_Akt_signaling_pathway_hsa04151 19 352 7.066e-13 3.34e-12
12 Oocyte_meiosis_hsa04114 13 124 8.979e-13 3.891e-12
13 Hedgehog_signaling_pathway_hsa04340 8 47 4.76e-10 1.904e-09
14 FoxO_signaling_pathway_hsa04068 11 132 6.65e-10 2.47e-09
15 Focal_adhesion_hsa04510 10 199 4.988e-07 1.729e-06
16 Rap1_signaling_pathway_hsa04015 10 206 6.848e-07 2.225e-06
17 Sphingolipid_signaling_pathway_hsa04071 8 118 7.651e-07 2.34e-06
18 AMPK_signaling_pathway_hsa04152 8 121 9.265e-07 2.677e-06
19 p53_signaling_pathway_hsa04115 6 68 4.212e-06 1.153e-05
20 Cytokine_cytokine_receptor_interaction_hsa04060 10 270 7.726e-06 2.009e-05
21 Apelin_signaling_pathway_hsa04371 7 137 2.471e-05 6.117e-05
22 Regulation_of_actin_cytoskeleton_hsa04810 8 208 4.969e-05 0.0001175
23 MAPK_signaling_pathway_hsa04010 9 295 0.0001004 0.0002269
24 Endocytosis_hsa04144 8 244 0.0001509 0.0003269
25 Notch_signaling_pathway_hsa04330 3 48 0.003358 0.006984
26 Apoptosis_hsa04210 4 138 0.01106 0.02212
27 ErbB_signaling_pathway_hsa04012 3 85 0.01623 0.03126
28 Apoptosis_multiple_species_hsa04215 2 33 0.01803 0.03349
29 Jak_STAT_signaling_pathway_hsa04630 4 162 0.01887 0.03384
30 cGMP_PKG_signaling_pathway_hsa04022 3 163 0.08245 0.1429
31 cAMP_signaling_pathway_hsa04024 3 198 0.1274 0.2136
32 Phagosome_hsa04145 2 152 0.2457 0.3872
33 Ras_signaling_pathway_hsa04014 2 232 0.4267 0.6339

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1 PVT1 hsa-miR-195-3p;hsa-miR-22-3p;hsa-miR-28-5p;hsa-miR-30c-5p;hsa-miR-30e-5p;hsa-miR-328-3p;hsa-miR-340-3p;hsa-miR-378a-3p;hsa-miR-455-3p;hsa-miR-505-5p 10 YWHAZ Sponge network 2.645 0 0.521 0 0.567
2

GAS5

 hsa-miR-193b-3p;hsa-miR-195-3p;hsa-miR-22-3p;hsa-miR-28-5p;hsa-miR-30a-5p;hsa-miR-340-3p;hsa-miR-374a-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-7-1-3p 10 YWHAZ Sponge network 1.966 0 0.521 0 0.559
3 MIR4435-1HG hsa-miR-195-3p;hsa-miR-22-3p;hsa-miR-28-5p;hsa-miR-328-3p;hsa-miR-374a-3p;hsa-miR-378a-3p;hsa-miR-505-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-7-1-3p 10 YWHAZ Sponge network 2.541 0 0.521 0 0.548
4 LINC00511 hsa-miR-193b-3p;hsa-miR-195-3p;hsa-miR-22-3p;hsa-miR-28-5p;hsa-miR-30e-5p;hsa-miR-328-3p;hsa-miR-378a-3p;hsa-miR-455-3p;hsa-miR-505-5p;hsa-miR-7-1-3p 10 YWHAZ Sponge network 2.468 0 0.521 0 0.541
5

DHRS4-AS1

 hsa-miR-106b-5p;hsa-miR-140-3p;hsa-miR-146b-5p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-301a-3p 10 TEAD1 Sponge network -0.646 0.01829 -0.192 0.10455 0.529
6

SNHG17

 hsa-miR-193b-3p;hsa-miR-195-3p;hsa-miR-22-3p;hsa-miR-28-5p;hsa-miR-30e-5p;hsa-miR-328-3p;hsa-miR-378a-3p;hsa-miR-451a;hsa-miR-505-5p;hsa-miR-590-3p 10 YWHAZ Sponge network 1.214 0 0.521 0 0.512
7 LINC00982 hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-192-3p;hsa-miR-193b-3p;hsa-miR-193b-5p;hsa-miR-194-5p;hsa-miR-197-3p;hsa-miR-224-3p;hsa-miR-365a-3p;hsa-miR-550a-5p 11 WTIP Sponge network -0.089 0.85759 -0.083 0.6902 0.506
8

DHRS4-AS1

 hsa-miR-106b-5p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-29a-5p;hsa-miR-301a-3p;hsa-miR-769-5p;hsa-miR-877-5p;hsa-miR-93-3p 12 BMPR2 Sponge network -0.646 0.01829 -0.736 0 0.493
9

CTC-297N7.9

 hsa-miR-1301-3p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-182-5p;hsa-miR-185-5p;hsa-miR-3127-5p;hsa-miR-338-3p;hsa-miR-769-3p;hsa-miR-877-5p;hsa-miR-93-3p 11 DLG2 Sponge network -1.632 0 -1.947 0 0.473
10 RP11-37B2.1 hsa-miR-193b-3p;hsa-miR-195-3p;hsa-miR-22-3p;hsa-miR-28-5p;hsa-miR-30e-5p;hsa-miR-328-3p;hsa-miR-378a-3p;hsa-miR-455-3p;hsa-miR-505-5p;hsa-miR-664a-3p 10 YWHAZ Sponge network 1.504 0 0.521 0 0.473
11

HCG11

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-501-3p;hsa-miR-93-5p 11 TGFBR2 Sponge network -0.781 0 -0.523 3.0E-5 0.472
12

HCG11

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-148b-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-301a-3p;hsa-miR-362-3p;hsa-miR-455-5p;hsa-miR-618;hsa-miR-877-5p;hsa-miR-93-5p 16 BMPR2 Sponge network -0.781 0 -0.736 0 0.47
13

GAS5

 hsa-let-7a-2-3p;hsa-let-7g-3p;hsa-miR-101-3p;hsa-miR-125b-5p;hsa-miR-139-5p;hsa-miR-140-5p;hsa-miR-144-3p;hsa-miR-27b-3p;hsa-miR-345-5p;hsa-miR-590-3p 10 BBC3 Sponge network 1.966 0 0.805 0 0.454
14

RP11-12A2.3

 hsa-miR-1301-3p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-30d-5p;hsa-miR-338-3p;hsa-miR-877-5p;hsa-miR-92a-3p;hsa-miR-92b-3p;hsa-miR-93-3p 16 DLG2 Sponge network -4.779 0 -1.947 0 0.452
15 RP11-517P14.2 hsa-miR-106b-5p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-29a-5p;hsa-miR-301a-3p;hsa-miR-769-5p;hsa-miR-93-5p 10 BMPR2 Sponge network -0.191 0.49845 -0.736 0 0.436
16

MAGI2-AS3

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-454-3p;hsa-miR-92a-3p;hsa-miR-93-5p 12 TGFBR2 Sponge network -1.801 0 -0.523 3.0E-5 0.428
17

LINC01018

 hsa-miR-1301-3p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-338-3p;hsa-miR-421;hsa-miR-877-5p 12 DLG2 Sponge network -3.231 0 -1.947 0 0.421
18 RP11-290F5.1 hsa-miR-1301-3p;hsa-miR-15b-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-338-3p;hsa-miR-3928-3p;hsa-miR-421;hsa-miR-769-5p;hsa-miR-940 11 DLG2 Sponge network -1.679 5.0E-5 -1.947 0 0.418
19

HCG11

 hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-186-5p;hsa-miR-192-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-193b-5p;hsa-miR-194-5p;hsa-miR-197-3p;hsa-miR-362-3p;hsa-miR-550a-5p 12 WTIP Sponge network -0.781 0 -0.083 0.6902 0.416
20

SNHG17

 hsa-let-7a-2-3p;hsa-let-7g-3p;hsa-miR-101-3p;hsa-miR-125b-5p;hsa-miR-139-5p;hsa-miR-140-5p;hsa-miR-144-3p;hsa-miR-27b-3p;hsa-miR-345-5p;hsa-miR-590-3p 10 BBC3 Sponge network 1.214 0 0.805 0 0.412
21

MAGI2-AS3

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-148b-3p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-301a-3p;hsa-miR-30d-5p;hsa-miR-362-3p;hsa-miR-455-5p;hsa-miR-532-5p;hsa-miR-671-5p;hsa-miR-769-5p;hsa-miR-877-5p;hsa-miR-92a-3p;hsa-miR-93-3p;hsa-miR-93-5p 20 BMPR2 Sponge network -1.801 0 -0.736 0 0.408
22 RP11-175O19.4 hsa-miR-193b-3p;hsa-miR-195-3p;hsa-miR-22-3p;hsa-miR-28-5p;hsa-miR-30c-5p;hsa-miR-30e-5p;hsa-miR-328-3p;hsa-miR-378a-3p;hsa-miR-455-3p;hsa-miR-505-5p 10 YWHAZ Sponge network 0.743 0 0.521 0 0.405
23

LDLRAD4-AS1

 hsa-miR-106b-5p;hsa-miR-132-3p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-3127-5p;hsa-miR-454-3p;hsa-miR-589-3p 10 FZD4 Sponge network -3.366 0 -0.346 0.01097 0.404
24 RP1-228H13.5 hsa-miR-193b-3p;hsa-miR-195-3p;hsa-miR-22-3p;hsa-miR-28-5p;hsa-miR-30a-5p;hsa-miR-30c-5p;hsa-miR-30e-5p;hsa-miR-328-3p;hsa-miR-455-3p;hsa-miR-576-5p 10 YWHAZ Sponge network 1.554 0 0.521 0 0.402
25

AF064858.6

 hsa-miR-1301-3p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-30d-5p;hsa-miR-338-3p;hsa-miR-421;hsa-miR-877-5p;hsa-miR-93-3p;hsa-miR-940 11 DLG2 Sponge network -2.163 0.0001 -1.947 0 0.402
26 AC104809.2 hsa-miR-1301-3p;hsa-miR-148b-3p;hsa-miR-182-5p;hsa-miR-25-3p;hsa-miR-3127-5p;hsa-miR-3928-3p;hsa-miR-769-3p;hsa-miR-769-5p;hsa-miR-92b-3p;hsa-miR-940 10 DLG2 Sponge network -9.371 0 -1.947 0 0.396
27

DIO3OS

 hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-186-5p;hsa-miR-193b-3p;hsa-miR-197-3p;hsa-miR-224-3p;hsa-miR-34a-5p;hsa-miR-361-3p;hsa-miR-3615;hsa-miR-550a-5p 10 WTIP Sponge network -3.204 0 -0.083 0.6902 0.395
28 GUSBP11 hsa-miR-193b-3p;hsa-miR-195-3p;hsa-miR-22-3p;hsa-miR-28-5p;hsa-miR-30a-5p;hsa-miR-30e-5p;hsa-miR-328-3p;hsa-miR-374a-3p;hsa-miR-378a-3p;hsa-miR-455-3p;hsa-miR-505-5p 11 YWHAZ Sponge network 2.066 0 0.521 0 0.386
29

RP11-166D19.1

 hsa-miR-106b-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-32-5p;hsa-miR-324-3p;hsa-miR-330-5p;hsa-miR-361-5p;hsa-miR-484;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-92a-3p;hsa-miR-940 18 FZD4 Sponge network -0.244 0.28835 -0.346 0.01097 0.384
30

DNM3OS

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-148b-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-590-5p;hsa-miR-618;hsa-miR-93-3p;hsa-miR-93-5p 13 BMPR2 Sponge network -2.094 1.0E-5 -0.736 0 0.382
31 RP11-54O7.3 hsa-miR-107;hsa-miR-140-3p;hsa-miR-15b-5p;hsa-miR-192-3p;hsa-miR-193b-3p;hsa-miR-193b-5p;hsa-miR-194-5p;hsa-miR-224-3p;hsa-miR-34a-5p;hsa-miR-362-3p;hsa-miR-550a-5p;hsa-miR-589-5p 12 WTIP Sponge network -3.012 0 -0.083 0.6902 0.377
32

LDLRAD4-AS1

 hsa-miR-1301-3p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-3127-5p;hsa-miR-421;hsa-miR-93-3p 13 DLG2 Sponge network -3.366 0 -1.947 0 0.374
33 LINC00238 hsa-miR-1301-3p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-338-3p;hsa-miR-93-3p 12 DLG2 Sponge network -4.997 0 -1.947 0 0.37
34 RP11-253E3.3 hsa-miR-107;hsa-miR-192-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-193b-5p;hsa-miR-194-5p;hsa-miR-33b-5p;hsa-miR-362-3p;hsa-miR-365a-3p;hsa-miR-589-5p 10 WTIP Sponge network 0.292 0.31072 -0.083 0.6902 0.367
35

LINC00885

 hsa-miR-1301-3p;hsa-miR-148b-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-32-3p;hsa-miR-3928-3p;hsa-miR-877-5p 10 DLG2 Sponge network -4.686 0 -1.947 0 0.364
36

RP11-12A2.3

 hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-301a-3p;hsa-miR-30d-5p;hsa-miR-671-5p;hsa-miR-877-5p;hsa-miR-92a-3p;hsa-miR-93-3p;hsa-miR-93-5p 16 BMPR2 Sponge network -4.779 0 -0.736 0 0.362
37

MAGI2-AS3

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-10b-3p;hsa-miR-221-3p;hsa-miR-30d-5p;hsa-miR-330-5p;hsa-miR-362-3p;hsa-miR-500a-5p;hsa-miR-501-5p;hsa-miR-532-5p;hsa-miR-766-3p 11 AMOT Sponge network -1.801 0 -0.898 0.00079 0.361
38

MAGI2-AS3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-1266-5p;hsa-miR-15b-5p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-425-5p;hsa-miR-589-3p;hsa-miR-616-5p;hsa-miR-9-5p;hsa-miR-92a-3p;hsa-miR-93-5p 16 CCND1 Sponge network -1.801 0 -0.902 1.0E-5 0.359
39

LINC00924

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-148b-3p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-301a-3p;hsa-miR-877-5p;hsa-miR-93-5p 11 BMPR2 Sponge network -0.391 0.1281 -0.736 0 0.357
40

SOCS2-AS1

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-148b-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-301a-3p;hsa-miR-532-5p;hsa-miR-671-5p;hsa-miR-93-3p;hsa-miR-93-5p 13 BMPR2 Sponge network -0.984 3.0E-5 -0.736 0 0.355
41

RP11-166D19.1

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-148b-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-301a-3p;hsa-miR-532-5p;hsa-miR-590-5p;hsa-miR-618;hsa-miR-877-5p;hsa-miR-92a-3p;hsa-miR-93-3p 17 BMPR2 Sponge network -0.244 0.28835 -0.736 0 0.348
42

RP11-12A2.3

 hsa-let-7d-5p;hsa-miR-106b-5p;hsa-miR-132-3p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-330-5p;hsa-miR-92a-3p 11 FZD4 Sponge network -4.779 0 -0.346 0.01097 0.342
43

RP11-7F17.3

 hsa-let-7d-5p;hsa-miR-106b-5p;hsa-miR-132-3p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-3127-5p;hsa-miR-324-3p;hsa-miR-330-5p;hsa-miR-940 12 FZD4 Sponge network -0.873 0.00204 -0.346 0.01097 0.341
44

RP11-685F15.1

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-148b-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-362-3p;hsa-miR-93-5p 11 BMPR2 Sponge network -9.951 0 -0.736 0 0.34
45

SOCS2-AS1

 hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-140-3p;hsa-miR-146b-5p;hsa-miR-148b-3p;hsa-miR-151a-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-425-5p;hsa-miR-532-5p;hsa-miR-93-5p 16 TEAD1 Sponge network -0.984 3.0E-5 -0.192 0.10455 0.336
46

SMIM2-AS1

 hsa-miR-1301-3p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-3127-5p;hsa-miR-3928-3p;hsa-miR-877-5p;hsa-miR-940 13 DLG2 Sponge network -0.66 0.00587 -1.947 0 0.328
47

CASC2

 hsa-miR-130b-3p;hsa-miR-148b-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-362-3p;hsa-miR-532-5p;hsa-miR-618;hsa-miR-877-5p;hsa-miR-92a-3p;hsa-miR-93-5p 15 BMPR2 Sponge network -0.596 0.00187 -0.736 0 0.327
48

RP11-166D19.1

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-590-5p;hsa-miR-92a-3p 11 TGFBR2 Sponge network -0.244 0.28835 -0.523 3.0E-5 0.324
49

RP11-12A2.3

 hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-185-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-425-5p;hsa-miR-93-5p 13 TEAD1 Sponge network -4.779 0 -0.192 0.10455 0.323
50

LINC00885

 hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-29a-5p;hsa-miR-877-5p 10 BMPR2 Sponge network -4.686 0 -0.736 0 0.314
51

MIR497HG

 hsa-miR-106b-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-324-3p;hsa-miR-589-3p;hsa-miR-940 11 FZD4 Sponge network -0.886 0.00689 -0.346 0.01097 0.313
52

CASC2

 hsa-miR-128-3p;hsa-miR-130b-3p;hsa-miR-140-3p;hsa-miR-148b-3p;hsa-miR-16-1-3p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-532-5p;hsa-miR-92a-3p;hsa-miR-93-5p 11 RASSF6 Sponge network -0.596 0.00187 -0.749 0.0103 0.312
53 UCA1 hsa-miR-107;hsa-miR-140-3p;hsa-miR-15a-5p;hsa-miR-186-5p;hsa-miR-192-3p;hsa-miR-193b-3p;hsa-miR-193b-5p;hsa-miR-194-5p;hsa-miR-224-3p;hsa-miR-3615 10 WTIP Sponge network -3.413 0 -0.083 0.6902 0.304
54

RP11-119D9.1

 hsa-miR-1301-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-182-5p;hsa-miR-25-3p;hsa-miR-338-3p;hsa-miR-769-5p;hsa-miR-92b-3p;hsa-miR-93-3p;hsa-miR-940 10 DLG2 Sponge network -2.765 0 -1.947 0 0.303
55 LINC00261 hsa-miR-106b-5p;hsa-miR-132-3p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-3127-5p;hsa-miR-324-3p;hsa-miR-330-5p;hsa-miR-454-3p;hsa-miR-589-3p;hsa-miR-629-3p;hsa-miR-940 11 FZD4 Sponge network -1.194 0 -0.346 0.01097 0.3
56

RP11-250B2.6

 hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-93-5p 10 TEAD1 Sponge network -0.98 2.0E-5 -0.192 0.10455 0.299
57

MAGI2-AS3

 hsa-miR-1301-3p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-30d-5p;hsa-miR-3127-5p;hsa-miR-3928-3p;hsa-miR-421;hsa-miR-769-3p;hsa-miR-769-5p;hsa-miR-877-5p;hsa-miR-92a-3p;hsa-miR-93-3p;hsa-miR-940 18 DLG2 Sponge network -1.801 0 -1.947 0 0.298
58

DHRS4-AS1

 hsa-miR-1301-3p;hsa-miR-146b-5p;hsa-miR-148b-5p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-421;hsa-miR-769-3p;hsa-miR-769-5p;hsa-miR-877-5p;hsa-miR-93-3p 13 DLG2 Sponge network -0.646 0.01829 -1.947 0 0.284
59

RP11-119D9.1

 hsa-miR-148b-3p;hsa-miR-155-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-181d-5p;hsa-miR-21-5p;hsa-miR-23a-3p;hsa-miR-330-5p;hsa-miR-338-3p;hsa-miR-93-3p 11 MPP5 Sponge network -2.765 0 -0.288 0.00156 0.284
60

RP11-166D19.1

 hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-151a-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-425-5p;hsa-miR-532-5p 12 TEAD1 Sponge network -0.244 0.28835 -0.192 0.10455 0.276
61

RP11-12A2.3

 hsa-miR-148b-3p;hsa-miR-155-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-181d-5p;hsa-miR-21-5p;hsa-miR-23a-3p;hsa-miR-330-5p;hsa-miR-338-3p;hsa-miR-93-3p 11 MPP5 Sponge network -4.779 0 -0.288 0.00156 0.274
62

CASC2

 hsa-miR-103a-3p;hsa-miR-107;hsa-miR-16-1-3p;hsa-miR-221-3p;hsa-miR-362-3p;hsa-miR-500a-5p;hsa-miR-501-5p;hsa-miR-532-5p;hsa-miR-618;hsa-miR-766-3p 10 AMOT Sponge network -0.596 0.00187 -0.898 0.00079 0.272
63

RP11-250B2.6

 hsa-miR-106b-5p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-301a-3p;hsa-miR-30d-5p;hsa-miR-93-5p 10 BMPR2 Sponge network -0.98 2.0E-5 -0.736 0 0.272
64 RP11-7K24.3 hsa-miR-107;hsa-miR-140-3p;hsa-miR-15a-5p;hsa-miR-192-3p;hsa-miR-193a-5p;hsa-miR-193b-3p;hsa-miR-193b-5p;hsa-miR-194-5p;hsa-miR-197-3p;hsa-miR-365a-3p 10 WTIP Sponge network -0.157 0.7852 -0.083 0.6902 0.272
65 RP11-1018N14.5 hsa-miR-106b-5p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-29a-5p;hsa-miR-301a-3p;hsa-miR-455-5p;hsa-miR-769-5p;hsa-miR-93-5p 12 BMPR2 Sponge network -0.573 0.20573 -0.736 0 0.27
66 RP11-289F5.1 hsa-miR-1301-3p;hsa-miR-148b-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-769-3p 10 DLG2 Sponge network -6.122 0 -1.947 0 0.268
67 MIR22HG hsa-miR-106b-5p;hsa-miR-128-3p;hsa-miR-148b-3p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-33a-3p;hsa-miR-532-5p;hsa-miR-92a-3p;hsa-miR-93-5p 11 RASSF6 Sponge network -0.234 0.09523 -0.749 0.0103 0.266
68

LDLRAD4-AS1

 hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-25-3p;hsa-miR-301a-3p;hsa-miR-671-5p;hsa-miR-93-3p;hsa-miR-93-5p 12 BMPR2 Sponge network -3.366 0 -0.736 0 0.263
69

MAGI2-AS3

 hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-425-5p;hsa-miR-532-5p;hsa-miR-93-5p 11 TEAD1 Sponge network -1.801 0 -0.192 0.10455 0.26
70 RP11-539I5.1 hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-194-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-30b-3p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-32-3p 11 FZD3 Sponge network -1.111 0.02467 -0.432 0.07605 0.259
71

RP11-7F17.3

 hsa-miR-1301-3p;hsa-miR-15b-3p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-3127-5p;hsa-miR-769-5p;hsa-miR-93-3p;hsa-miR-940 10 DLG2 Sponge network -0.873 0.00204 -1.947 0 0.258
72

SOCS2-AS1

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-140-3p;hsa-miR-148b-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-532-5p;hsa-miR-93-5p 11 RASSF6 Sponge network -0.984 3.0E-5 -0.749 0.0103 0.257
73

RP11-685F15.1

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-454-3p;hsa-miR-93-5p 10 TGFBR2 Sponge network -9.951 0 -0.523 3.0E-5 0.254
74

SMIM2-AS1

 hsa-let-7d-5p;hsa-miR-106b-5p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-3127-5p;hsa-miR-330-5p;hsa-miR-589-3p;hsa-miR-629-3p;hsa-miR-940;hsa-miR-98-5p 13 FZD4 Sponge network -0.66 0.00587 -0.346 0.01097 0.253
75

RP11-166D19.1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-1266-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-425-5p;hsa-miR-589-3p;hsa-miR-616-5p;hsa-miR-92a-3p;hsa-miR-942-5p 17 CCND1 Sponge network -0.244 0.28835 -0.902 1.0E-5 0.253

Quest ID: 130dbfeee57d9e93e02aecebfd493d3e